CMS-10418 MLR Form Instructions

Centers for Medicare & Medicaid Services (CMS)
Medical Loss Ratio (MLR) Annual Reporting Form
Filing Instructions for the 2022 MLR Reporting Year
Table of Contents
Instructions for the 2022 MLR Reporting Year .............................................................................................1
Changes to the 2022 MLR Annual Reporting Form ......................................................................................3
General Instructions ...................................................................................................................................4
Column Definitions for MLR Annual Reporting Form − Parts 1 and 2 ....................................................8
Instructions for MLR Annual Reporting Form − Part 1 (Summary of Data)...........................................12
Instructions for MLR Annual Reporting Form − Part 2 (Premium and Claims) .....................................25
Instructions for MLR Annual Reporting Form − Part 3 (MLR and Rebate Calculation) ........................37
Instructions for MLR Annual Reporting Form – Part 4 (Rebate Disbursement) .....................................48
Instructions for MLR Annual Reporting Form – Part 5 (Additional Responses) ....................................51
Instructions for MLR Annual Reporting Form − Part 6 (Expense Allocation Methodology) .................52

PRA Disclosure Statement
According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it
displays a valid OMB control number. The valid OMB control number for this information collection is 0938-1164. The time
required to complete this information collection is estimated to average 63 hours or 3,804 minutes per response, including the
time to review instructions, search existing data resources, gather the data needed and complete and review the information
collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please
write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Mail Stop C4-26-05, Baltimore, Maryland
21244-1850.

Instructions for the 2022 MLR Reporting Year
These are the filing instructions for the report to the Secretary required by section 2718 of the Public
Health Service Act (PHSA), which includes elements that make up the medical loss ratio (MLR) and the
calculation and provision of rebates to enrollees. The data included in the MLR Annual Reporting Form
(MLR Form) are the exact data that will be used to calculate an issuer’s MLR and rebates, if any, under
section 2718 of the PHSA and the implementing regulation, codified at 45 CFR Part 158.
The MLR implementing regulations can be found at:
http://www.cms.gov/cciio/resources/regulations-and-guidance#Medical-Loss-Ratio.
These MLR Form Filing Instructions only apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions will be revised to reflect changes that apply to the filing years
subsequent to 2022. Filing requires a one-time registration by the issuer through the secured CMS
Enterprise Portal for the Health Insurance Oversight System (HIOS) to submit its report to the Secretary.
If an issuer registered for a previous MLR reporting year, it does not need to reregister, but will need to
confirm or update its issuer associations. The CMS Enterprise Portal can be accessed at
https://portal.cms.gov/portal.
For information regarding HIOS, including user roles, company/issuer associations, downloading and
submitting MLR Form templates, and attestation, please refer to the HIOS User Manual, which will be
posted on the CCIIO MLR Training webpage, https://www.cms.gov/cciio/Resources/TrainingResources/index.html#Medical_Loss_Ratio.
References are made in these instructions to the National Association of Insurance Commissioners
(NAIC) Statements of Statutory Accounting Principles (SSAP) and Supplemental Health Care Exhibit
(SHCE) (as filed by many issuers with the NAIC) in effect for the MLR reporting year. These references
are solely for the convenience of the filer in identifying the information needed for this MLR Form.
These Filing Instructions are to be used in completing the MLR Form by all health insurance issuers
(issuers) offering health insurance coverage subject to section 2718 of the PHSA and the MLR
implementing regulations. All terms used in these Filing Instructions that are not defined here have the
meaning used in 45 CFR Part 158 and the PHSA.
The term “health insurance coverage” means benefits consisting of medical care (provided directly,
through insurance or reimbursement, or otherwise and including items and services paid for as medical
care) under any hospital or medical service policy or certificate, hospital or medical service plan contract,
or health maintenance organization contract offered by a health insurance issuer. The definition includes
any insurance product, such as drug, chiropractic, or mental health coverage, whether sold as a standalone product or in conjunction with any other health insurance coverage, unless specifically identified as
“excepted benefits” by the PHSA.
An MLR Form must be prepared and submitted for each State in which the issuer has written direct health
insurance coverage or has direct amounts paid, incurred, or unpaid for the provision of health care
services. In addition, the issuer must submit a Grand Total (GT) template containing the grand total of its
business in all States. (Note: The experience of expatriate and student health plans is aggregated on a
national basis and should be reported only on the GT template.) Parts 1 and 2, both the 12/31 and
3/31 columns, must be completed for each State in which the issuer provides any health insurance
coverage subject to MLR requirements, even if a particular State will show $0 earned premium in Part 1.
1

Except for the GT template, Parts 3 through 5 must be completed for any State in which there are nonzero amounts in Part 1. Part 3 through 5 of the GT template should only be completed for Student Health
Plans. Part 6 should be completed in the GT template only. However, while an issuer is not required to
submit State templates for those States where the issuer has no business subject to MLR, the GT template
should include the issuer’s entire nationwide business for Columns 40-43. Note that this may cause
Columns 40-43 on the GT template to show higher amounts than the sum of the corresponding amounts
on the State templates.
If you have any questions about the Form Instructions or uploading the MLR Forms into HIOS, please
refer to the below contact information for assistance:
MLR Contact Information
Email:

MLR policy matters and MLR Form and Instructions: MLRQuestions@cms.hhs.gov.
HIOS technical matters: CMS_FEPS@cms.hhs.gov.

Telephone:
HIOS technical matters: 855-267-1515 (Marketplace Service Desk)

2

Changes to the 2022 MLR Annual Reporting Form
The MLR Form has been updated to incorporate provisions in 45 CFR Part 158 that are effective for the
2022 MLR reporting year. Below are the most significant changes.
Clarifications: Clarified instructions for reporting of risk adjustment, QIA, and incurred claims
(including provider incentives and bonuses and prescription drug rebates and price concessions).
Merged markets: Removed Vermont.

3

General Instructions
Company Information Tab
The information in the Company Information tab of the MLR Form is pre-populated. If any of the
information needs to be changed, please refer to the Company/Issuer Associations tab in HIOS (see
section 3.1.1 of the HIOS User Manual).
Recommended Order for Completing the MLR Form

Part 2
Premium
and Claims

Part 1

Summary of
Data

Part 3

MLR and
Rebate
Calculation

Parts 4-6

Rebate Disbursement
Additional Responses
Expense Allocation

The information populated into Part 2 of the MLR Form is used to populate certain cells in Part 1, and
information in Parts 1 and 2 is used for certain calculations in Parts 3 and 4. Therefore, it is suggested that
Part 2 be completed first, followed by Part 1, Part 3, and then Parts 4-6. (Note: Part 6 is only completed in
the GT template.)
General Submission Process
Submission of the MLR templates should be completed in the following order:
1) Upload the zip file that includes all required MLR templates.
2) Wait for the automated email from HIOS confirming that the MLR upload was successful.
3) Complete attestation only after you successfully upload MLR templates.
General Requirements for Reporting Certain Types of Business
Reinsurance
Experience under a 100% assumption reinsurance agreement (with a novation) must be reported
by the assuming issuer as direct business, for the entire MLR reporting year during which the
policies are assumed and must not be reported by the ceding issuer.
Reporting of 100% indemnity reinsurance and administrative agreements is limited to those
agreements both entered into and effective prior to March 23, 2010, where the assuming entity is
responsible for 100% of the ceding entity’s financial risk and takes on all of the administration of
the block of business. Experience under those indemnity reinsurance and administrative
agreements must be reported by the assuming issuer as direct business, and must not be reported
by the ceding issuer.
If a reinsurance arrangement does not meet the exact criteria specified in the two preceding
paragraphs, the experience under that reinsurance arrangement must be reported on a direct basis
by the ceding issuer and not by the assuming issuer. The reinsurance premium and claims amounts
must also be reported by the ceding and assuming issuers on Part 1, Lines 1.4 and 2.5, in the 12/31
column for the relevant market.

4

Closed Blocks of Business
All health insurance issuers offering health insurance coverage subject to Section 2718 of the
PHSA must submit an MLR report. CMS will use its enforcement discretion and will not initiate
an enforcement action against an issuer of group or individual health insurance coverage who fails
to submit a full MLR report if the issuer’s only health insurance coverage consists of
grandfathered or transitional (grandmothered) plans in closed blocks of business. To qualify, the
issuer must provide and the issuer’s CFO and CEO must attest to the following information
regarding the applicable MLR reporting year:
1. The issuer has ceased offering health insurance coverage, as defined by §2791(b)(1) of the PHSA,
in the small group, large group, and individual health insurance markets in every State in which it
is licensed to offer health insurance coverage;
2. The issuer has only grandfathered health plans (as defined in 45 CFR §147.140(a)) or transitional
health plans (as described in the Nov. 14, 2013 CMS letter to State Insurance Commissioners and
related technical guidance 1) in closed blocks of business that are in run-off;
3. The issuer did not submit a Supplemental Health Care Exhibit (SHCE) or other similar State filing
for business during the applicable MLR reporting year, has been exempted from filing a SHCE or
similar State filing by the State in which it is domiciled, and submits to CMS evidence of this
exemption on State letterhead. If the issuer is not subject to a SHCE or similar State filing
requirement, this criterion is not applicable;
4. The issuer has less than 1,000 life-years nationwide (combined for all health insurance coverage)
for the MLR reporting year; and
5. The issuer has non-credible experience in each State market in which it provides coverage. The
issuer must report the number of life-years in each State market for each MLR reporting year that
is aggregated to determine whether the issuer has non-credible experience.
Like all issuers that are subject to the MLR reporting requirements, a company that meets all of
the criteria described above must register with the MLR module of HIOS, and complete, update,
or confirm the “company issuer association” form in HIOS. A company that meets all of the
above criteria may select “yes” in the “small closed blocks of business” box on the HIOS company
issuer association confirmation. When a company that selects “yes” in the “small closed blocks of
business” box downloads the MLR reporting form from HIOS, it may complete only Part 3, Line
3.1 of the MLR reporting form for every State and market in which it has health insurance
coverage. The company should use HIOS’ “upload supplemental material” function to submit an
attestation statement that affirms the criteria described above. The company should also upload
any State Supplemental Health Care Exhibit (or other similar State required filing) exemption it
has received from its State of domicile. The company should then complete the HIOS process.
Issuers satisfying the above criteria may instead choose to complete the full MLR form for their
grandfathered or transitional plans in closed blocks of business. The option described in this
closed block of business policy is intended to reduce MLR reporting burden.
If CMS determines that an issuer does not satisfy the criteria described above, CMS will notify the
issuer that it must complete the full MLR reporting form as specified in 45 CFR Part 158.

See Extended Non-Enforcement of Affordable Care Act-Compliance With Respect to Certain Policies, issued March 23,
2022, available at https://www.cms.gov/files/document/extension-limited-non-enforcement-policy-through-calendar-year2023-and-later-benefit-years.pdf.
1

5

Deferred Business
If, for any aggregation as defined in 45 CFR §158.121, 50% or more of the total earned premium
for an MLR reporting year is attributable to policies newly issued in that MLR reporting year, then
the experience of these policies may be deferred, at the option of the issuer. For the purposes of
this provision, policies are not considered to be “newly issued” if issued to previously enrolled
policyholders as a result of enrollment changes (e.g., adding dependents or new employees), or as
a result of price or plan changes such as modifications to cost-sharing or provider networks, or
policies were transferred from one issuer to another as a result of a merger or split of the company
or transferred between affiliated issuers. If an issuer defers the reporting of newer business as
provided in this paragraph, then the experience of such policies must be excluded from the MLR
calculation for the MLR reporting year in which the experience occurred and must be added to the
experience reported in the following MLR reporting year (i.e., treated as if the experience
occurred in the following MLR reporting year for the next three years).
Allocation of Expenses
Each expense must be reported under only one type of expense, unless a portion of the expense fits
under the definition of or criteria for one type of expense and the remainder fits into a different
type of expense, in which case the expense must be pro-rated between the two (or more) types of
expenses. Expenditures that benefit more than one affiliate must be allocated, on a pro rata basis,
between the affiliates that benefit from these expenditures. Expenditures that benefit all lines of
business or products, including but not limited to those that are for or benefit self-funded plans,
must be reported on a pro rata basis.
Aggregation of Experience
An issuer’s experience, aggregated by individual, small group, and large group markets, with
respect to each policy must be included on the report submitted with respect to the State where the
policy was issued, except as specified below.
Group Coverage in Multiple States:
Group coverage issued by a single issuer to an employer that covers employees in multiple States
must be reported for the State where the contract is sitused. Situs of the contract is the jurisdiction
in which the contract is issued or delivered, as stated in the contract.
Dual-Contract Group Health Coverage:
If an issuer has a group health plan which provides only in-network coverage and an affiliate
issuer provides only out-of-network coverage solely for the purpose of providing a group health
plan that offers both in-network and out-of-network benefits, the issuer may choose to treat the
out-of-network experience of the affiliate that provides the out-of-network coverage as if it were
related to the contract providing the in-network coverage. If an issuer chooses this method of
aggregation, it must do so for a minimum of three consecutive reporting years and the affiliate that
provides the out-of-network coverage must not report this experience. After an issuer applies this
method for the initial three consecutive reporting years, the issuer may either continue to apply
this method for any number of additional consecutive reporting years, or may choose to
discontinue applying this method.
Individual Business through an Association:
For individual business sold through an association, the issuer shall include the experience in the
State report for the issue State of the certificate of coverage.
6

Employer Business through Group Trust, Association, or MEWA:
For non-association health plan (AHP) employer-sponsored health insurance coverage issued
through a group trust, the issuer shall include the experience in the State report for the State where
the employer has its principal place of business. For employer-sponsored health insurance
coverage issued through a multiple employer welfare association (MEWA) that is not an AHP, the
issuer shall include the experience in the State report for the State where the MEWA has its
principal place of business (if the MEWA is the policyholder). For employer-sponsored health
insurance coverage issued through an AHP, where the AHP does not meet the requirements to be
capable of establishing a group health that is an employee welfare benefit plan, consistent with 29
C.F.R. § 2510.3-5 or with other applicable guidance, experience with respect to each employer
shall be reported as large group or small group based on the size of each employer and be reported
in each State based upon the aggregation rules for employer based insurance. For employersponsored health insurance coverage issued through an AHP where the AHP meets the
requirements to be capable of establishing a group health plan that is an employee welfare benefit
plan, consistent with 29 C.F.R. § 2510.3-5 or with other applicable guidance, experience should be
reported in the State report for the State where the policy is sitused and in the segment of the
group market that corresponds with the size of the AHP.
Definition of Small Group and Large Group:
The large group and small group markets are defined as those where health insurance coverage is
obtained by a large or small employer, respectively. Large employer and small employer are
defined by the number of employees employed; a small employer has 1 to 50 employees, but if a
State elects to use “100” employees as the upper limit for a small employer, then “100” must be
substituted for “50” employees.
• For the purposes of the MLR program, a sole proprietor or a sole proprietor’s spouse is not
considered a group of one. An employer’s number of employees is determined by
averaging the total number of all employees employed on business days during the
preceding calendar year. This includes each full-time, part-time, and seasonal employee.
Alternatively, an issuer may choose to determine an employer’s number of employees
using the applicable State counting method, unless the State method does not take into
account non-full-time employees, in which case the issuer must use the full-time
equivalent method described in section 4980H(c)(2) of the Internal Revenue Code if
electing this reporting option.
Non-Affiliate Business:
An issuer must report on this MLR Form only the business issued by the reporting entity. Business
that is written by an unaffiliated entity as part of a package provided to the enrollee (e.g., inpatient
coverage written by the reporting entity, outpatient coverage written by an unaffiliated separate
entity) must not be included in this MLR Form.
Merged Markets:
Issuers of health insurance coverage in the individual and small group markets that merge their
markets in accordance with state law (such as in Massachusetts and the District of Columbia)
should report all experience separately for the individual and small group markets, and combine it
only in MLR numerator, denominator, and credibility fields (Part 3, Lines 1.9, 2.3, 3.1, 3.3, and
5.6).

7

Column Definitions for MLR Annual Reporting Form − Parts 1 and 2
Health insurance coverage, Columns 1 through 15, includes policies that provide medical coverage,
including office visits, hospital, surgical, and major medical (illness and injury). Include risk contracts
and the Federal Employees Health Benefit Plan (FEHBP). Exclude from Columns 1–15 mini-med plans,
since they are reported separately in Columns 16–24 of each State MLR Form, and exclude expatriate
plans and student health plans reported in Columns 25–39 on the GT template.
Do not include in Columns 1–39 business specifically included in Columns 40–43 (e.g., uninsured or selffunded business, Medicare (Title XVIII, including Medicare Advantage), Medicaid (Title XIX), vision
only, dental only, State Children’s Health Insurance Program (SCHIP) (Title XXI), other Federal or State
government-sponsored coverage (other than the Federal Employees Health Benefits Program or nonFederal governmental plans, such as State or local government sponsored coverage for its employees),
and short-term, limited duration insurance as further defined in the PHSA). The experience for pharmacy,
chiropractic, or mental health coverage, whether sold as a stand-alone product or in conjunction with any
other health insurance coverage, should be reported with the health insurance coverage for the applicable
market if the coverage does not meet the definition of “excepted benefits” under the PHSA.
The experience of stop loss or excess of loss coverage for self-funded groups should be reported in Parts 1
and 2, Column 41 – Other Health Business Plans (business excluded by statute). Column 41 includes
information reported in Column 11 of the SHCE.
For any data element that is not separately reported in the financial statement filings to the issuer’s
regulatory authority, an issuer does not need to separately report that element in the 12/31 column of the
MLR Form. However, an issuer must separately report that data element in the 3/31 column as required
by 45 CFR Part 158 and as instructed in the MLR Form instructions. For example, an issuer may not
need to report the amount of contingent benefit and lawsuit reserves in Part 2, Line 2.13 in the 12/31
column, but must report such amounts in the 3/31 column. An issuer must still report, in the detail
provided by the MLR Form, the amounts for premiums and unearned premium reserves, taxes and fees,
claims and claims-related reserves, quality improving activities, and non-claims costs, in both the 12/31
and the 3/31 columns, to the extent the issuer reports such amounts to the issuer’s regulatory authority.
Columns 1, 6, 11, 16, 19, 22, 25, 30, 35, 40, 41, 42, 43 – Business as of 12/31 of the MLR reporting
year
Financial information reported for the 12/31 columns should generally equal the exact amounts
that were reported directly to the State regulatory authority of the issuer, including amounts that
may have been amended in the SHCE the issuer submitted to the NAIC prior to filing the MLR
Form.
Include:

Experience of policies in each of the relevant markets for the MLR reporting year,
as reported as of December 31, to the regulatory authority in the issuer’s State of
domicile or as filed on the NAIC SHCE filing for the MLR reporting year
regardless of incurred date.

Columns 2, 7, 12, 17, 20, 23, 36 – Business as of 3/31 of subsequent MLR reporting year
Financial information reported in the 3/31 columns should equal the amount of each element
related specifically to experience in the MLR reporting year and paid through March 31 of the
8

subsequent reporting year (incurred in 12, paid or received in 15), plus any provision for items
properly allocable to the MLR reporting year but not yet paid as of 3/31 of the following year,
except as otherwise noted in line instructions. For example, these columns could include
differences from the 12/31 columns in the upper limit for a small group and the lower limit for a
large group, if State group size regulations differ from Federal group size regulations. (See the
Definitions of Small Group and Large Group, in the General Instructions above.) These columns
could also include differences from the 12/31 columns in the accounting for the Federal risk
adjustment amounts. If the issuer elects to treat the out-of-network experience of an affiliate that
provides the out-of-network coverage as if it were related to the contract providing the in-network
coverage, the issuer must include such out-of-network experience in the 3/31 columns, as well as
separately report it in the Dual Contract columns (see the column definition below).
Include:

Experience of policies in each market, incurred, paid or received relevant only to
coverage provided during the MLR reporting year, reported as of March 31 of the
subsequent MLR reporting year.

Columns 3, 8, 13, 18, 21, 24, 37 – Dual Contract
If an issuer chooses to treat the out-of-network experience of an affiliate that provides the out-ofnetwork coverage as if it were related to the contract providing the in-network coverage, the issuer
must report the out-of-network experience in the 3/31 columns, as well as the Dual Contract
column.
Include:

Experience reported in columns 2, 7, 12, 17, 20, 23, and 36 that is attributable to
dual contracts. Note that these amounts are a subset of what is reported as of 3/31.

Columns 4, 9, 14, 38 – Deferred Newer Business from prior MLR reporting year
Include:

Experience from policies for the relevant market newly issued in the 2021 MLR
reporting year (PY1), previously deferred, as provided in the General Instructions.
Data elements constituting adjusted incurred claims for business deferred from the
preceding MLR reporting year should be restated as of 3/31 of the year following
the MLR reporting year.

Columns 5, 10, 15, 39 – Deferred Newer Business for the MLR reporting year
Include:

Columns 1–5
Include:

Policies for the relevant market newly issued in the 2022 MLR reporting year, as
defined more specifically in the General Instructions, deferred for reporting
purposes at the issuer’s option.
Individual Market
Health insurance where the policy is issued to an individual covering the individual
and his or her dependents in the individual market.

9

Columns 6–10
Include:
Columns 11–15
Include:
Columns 16–24
Include:
Columns 25–34
Include:

Columns 35–39

Small Group Market
All policies issued in the small group market (including fully insured State and
local government policies).
Large Group Market
All policies issued in the large group market (including the Federal Employees
Health Benefit Program and fully insured State and local government policies).
Mini-Med Plans
All policies that have a total annual limit of $250,000 or less for individual, small
group, and large group markets, in their respective columns.
Expatriate Plans (GT Template only. 12/31 column only)
All group policies written in the United States that provide coverage for employees
working outside their country of citizenship; working outside of their country of
citizenship and outside the employer’s country of domicile; or non-U.S. citizens
working in their home country. These policies are to be reported on a nationwide,
aggregated basis, separately for the small group and the large group markets, as of
12/31 on the GT template only.
Student Health Plans (GT template only)

Include:

All health insurance policies issued to students and their dependents pursuant to a
written agreement between the issuer and the institution of higher education, as
defined by 45 CFR §147.145.

Exclude:

Policies reported in other columns. Also exclude amounts paid to a provider for
services that do not represent reimbursement for covered services provided to an
enrollee and are directly covered by a student administrative health fee.

Column 40
Include:

Government Program Plans (Not Subject to Section 2718 of the PHSA)
Government sponsored programs that are not subject to section 2718 of the PHSA,
such as Medicaid (Title XIX), State Children’s Health Insurance Program (SCHIP)
(Title XXI), the Basic Health Program (established under section 1331 of the
PHSA), and other Federal or State government-sponsored coverage (other than the
Federal Employees Health Benefits Program or non-Federal governmental plans,
such as State or local government sponsored coverage for its employees).
Report the experience of the issuer’s government program plans for the MLR
reporting year as of December 31, as reported to the regulatory authority in the
issuer’s State of domicile or as filed on the NAIC SHCE filing for the MLR
reporting year.

10

Exclude:

Column 41

Medicare Advantage Part C and Medicare Part D stand-alone plans subject to the
Medicare MLR requirements pursuant to section 1857(e) of the Social Security
Act, reported in Column 42
Other Health Business (Not Subject to Section 2718 of the PHSA)

Information reported here is similar to that reported in the SHCE Part 1, Columns 9 and 10.
Report health plan arrangements that are not group or individual health insurance coverage
provided by a health insurance issuer. Report all other health care business that is not reported in
Columns 1–39, including stand-alone dental and vision coverage, long-term care, disability
income, etc.
Include:

Short-term, limited-duration insurance (as defined under 45 CFR §144.103);
supplemental coverage if offered as a separate policy, certificate, or contract of
insurance (45 CFR §146.145), including Medicare supplemental health insurance
(as defined under section 1882(g)(1) of the Social Security Act), coverage
supplemental to the coverage provided under chapter 55 of title 10, United States
Code, and similar supplemental coverage provided under a group health plan;
hospital or other fixed indemnity insurance, and specified disease or illness
coverage if offered under a separate policy, certificate, or contract of insurance (45
CFR §146.145), and other “excepted benefits” as specified by regulations
promulgated by HHS (45 CFR §146.145). The experience for pharmacy,
chiropractic, or mental health coverage, whether sold as a stand-alone product or in
conjunction with any other health insurance coverage, should be reported with the
health insurance coverage for the applicable market if the coverage does not meet
the definition of “excepted benefits” under the PHSA.
Report the experience of the issuer’s Other Business for the MLR reporting year as
of December 31, as reported to the regulatory authority in the issuer’s State of
domicile or as filed on the NAIC SHCE filing for the MLR reporting year.

Column 42
Include:
Column 43
Include:

Medicare MLR Business
Medicare Advantage Part C and Medicare Part D plans subject to the Medicare
MLR requirements pursuant to section 1857(e) of the Social Security Act.
Uninsured (Self-Funded) Plans
Plans for which a reporting entity, as an administrator, performs administrative
services such as claims processing for an employer that is at risk, and accordingly,
the administrator has not issued an insurance policy.
Report the experience of the issuer’s Uninsured (Self-Funded) Plans for the MLR
reporting year as of December 31, as reported to the regulatory authority in the
issuer’s State of domicile or as filed on the NAIC SHCE filing for the MLR
reporting year.

11

Instructions for MLR Annual Reporting Form − Part 1
(Summary of Data)
These MLR Form Filing Instructions apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions may be revised to reflect changes that apply to the filing years
subsequent to 2022.
In addition to the instructions below, the General Instructions and Column Definitions at the beginning of
these Filing Instructions apply to Part 1. The General Instructions and Column Definitions include
instructions regarding reporting of reinsurance, deferred business, individual business through an
association, employer business through a group trust or MEWA, group coverage in multiple States, and
dual contract group health coverage.
Please note that the MLR Form and Filing Instructions implement the requirements of 45 CFR Part 158
and are not identical to the definitions or instructions of the NAIC’s SHCE.
Section 1 – Premium
Line 1.1 – Total direct premium earned
Part 2, Lines 1.1 + 1.2 – 1.3 – 1.7 + 1.8 + 1.9 + 1.10
Line 1.2 – Federal high risk pools
Enter subsidies received or (assessments paid) under Federal high risk pools.
Line 1.3 – State high risk pools
Enter subsidies received or (assessments paid) under State high risk pools.
Exclude: Amounts included in Line 2.4.
Line 1.4 – Net assumed less ceded reinsurance premiums earned
The amount to net against the assumed reinsurance premiums earned is: the ceded reinsurance
premiums written; plus the change in unearned premium reserve that is transferred to the
company assuming the risk; plus the change in reserve credit taken other than for unearned
premiums.
Line 1.5 – Other adjustments due to MLR calculations – premiums
Include:

Any amounts excluded from premium for MLR calculation purposes that are
normally included in premiums for financial statement purposes.

Amounts for rate credits paid and the change in reserve for rate credits that were excluded
from Line 1.1 Total Direct Premiums Earned.

12

Line 1.6 – Risk revenue
Include:

Amounts charged by the reporting entity as a provider or intermediary for specified
medical services (e.g., full professional, dental, radiology, etc.) provided to the
policyholders or members of another issuer or reporting entity.

Unlike premiums that are collected from an employer group or individual member, risk
revenue is the prepaid (usually on a capitated basis) payment, made by another insurer or
reporting entity to the reporting issuer in exchange for services to be provided or offered by
such organization.
Section 2 – Claims
Line 2.1 – Total incurred claims
Part 2, Line 2.17.
Line 2.2 – Prescription drugs (informational only)
Include:

Expenses for prescription drugs and other pharmacy benefits covered by the
reporting entity.

Exclude: Prescription drug charges that are included in a hospital billing which should be
classified as Hospital/Medical Benefits.
Line 2.3 – Pharmaceutical rebates (informational only)
Line 2.4 – State stop loss, market stabilization, and claim/census based assessments (informational only)
Adjustments that must be included in incurred claims:
• Market stabilization payments or receipts by issuers that are directly tied to claims
incurred and other claims-based or census-based assessments
• State subsidies based on a stop-loss payment methodology
Adjustments that must be either included in or deducted from incurred claims:
• Payment to and from unsubsidized State programs designed to address distribution of
health risks across issuers via charges to low risk issuers that are distributed to high
risk issuers must be included in or deducted from incurred claims, as applicable
Line 2.5 – Net assumed less ceded claims incurred
Assumed reinsurance claims paid; plus the change in the assumed reinsurance claims liability
and aggregate assumed reinsurance claims reserve; less the ceded reinsurance claims paid; plus
the change in the ceded reinsurance claims liability and aggregate ceded reinsurance claims
reserve; less the change in claims related reinsurance recoverable.
Line 2.6 – Other adjustments due to MLR calculation – claims incurred

13

Any amounts excluded from claims for MLR calculation purposes that are normally included
in claims for financial statement purposes. For example, premium deficiency reserves are
excluded from contract reserves for MLR purposes in Part 2; thus, premium deficiency
reserves would be included on this Line. Include the adjustment for multi-option coverage
amounts (report as a negative amount if offsetting Part 2, Line 2.15).
Line 2.7 – Rebates paid
MLR rebates paid during the MLR reporting year.
Line 2.8 – Estimated rebates unpaid at the end of the previous MLR reporting year
Amount should equal Line 2.9 from the previous MLR reporting form.
Line 2.9 – Estimated rebates unpaid at the end of the MLR reporting year
MLR rebates estimated but unpaid as of the end of the MLR reporting year.
Line 2.10 – Fee-for-service and co-pay revenue (net of expenses)
Include:

Revenue recognized by the issuer for collection of co-payments from members and
revenue derived from health services rendered by reporting entity providers that are
not included in member policies (generally only applicable to staff-model HMOs).

Deduct:

Medical expenses associated with fee-for-service business.

Line 2.11 – Allowable claims recovered through fraud reduction efforts Part 2, Line 2.18.
Section 3 – Federal and State Taxes and Licensing or Regulatory Fees
PLEASE NOTE: Any amounts for ACA fees collected in advance of the MLR reporting year in which the
fee is payable may not be reported in Section 3. In most cases, the pre-tax underwriting gain/(loss) –
which should reflect all relevant revenue and expenses, including cost-sharing reduction amounts,
premium stabilization program amounts, and administrative expense amounts – is the most appropriate
basis for allocating income taxes; consequently, a loss is expected to yield a negative income tax
allocation.
Line 3.1 – Federal taxes and assessments incurred by the reporting issuer during the MLR reporting year
3.1a – Federal income taxes deductible from premiums in MLR calculations
Include:

Federal income taxes attributed to the MLR reporting year allocated to the
respective lines of business reported.

Exclude: Federal income taxes on investment income and capital gains.
3.1b – Patient Centered Outcomes Research Institute (PCORI) Fee

14

This fee is imposed on an issuer of a specified health insurance policy and a plan sponsor of an
applicable self-insured health plan.
Include:

PCORI fees attributed to applicable policies during the MLR reporting year.

3.1c – Reserved
3.1d – Other Federal taxes and assessments deductible from premium
Include:

Federal taxes and assessments (other than taxes and assessments that must be
reported on Lines 3.1a-b and 3.3a-b) allocated to the respective lines of business.

Exclude:
• Risk adjustment and Marketplace user fees. Report these fees on Line 3.3b.
• Fines, penalties, and fees for examinations by any Federal departments.
• Federal employment taxes (such as the Federal Insurance Contributions Act (FICA),
the Railroad Retirement Tax Act (RRTA), and the Federal Unemployment Act (FUTA)
taxes). Report these taxes on Line 5.5c.
Line 3.2 – State insurance, premium, and other taxes incurred by the reporting issuer during the MLR
reporting year (deductible from premium in MLR calculation)
3.2a – State income, excise, business, and other taxes, allocated to the respective lines of business
reported, that may be excluded from earned premium under 45 CFR §158.162(b) (1)
Include:
• Any industry wide (or subset) assessments (other than surcharges on specific claims)
paid to the State directly, or premium subsidies that are designed to cover the costs of
providing indigent care or other access to health care throughout the State, or market
stabilization redistributions, or cost transfers for the purpose of rate subsidies, not
directly tied to claims, and that are authorized by State law
• Contributions to State Reinsurance Programs, whether in form of fees, assessments, or
ceded premium.
• Guaranty fund assessments. Note: if such assessments will be offset in future years
through reductions in state taxes or through premium surcharges, as permitted by the
state, the issuer may defer reporting such guaranty fund assessments until the year(s) of
offset.
• Assessments of State industrial boards or other boards for operating expenses or for
benefits to sick employed persons in connection with disability benefit laws or similar
taxes levied by States
• Advertising required by law, regulation or ruling, except advertising associated with
investments
• State income, excise, and business taxes other than premium taxes
Exclude:
• Risk adjustment and Marketplace user fees. Report these fees on Line 3.3b.
• Fines, penalties, and fees for examinations by any State departments.

15

•

State employment taxes and assessments (such as State unemployment / reemployment
insurance, employment training, and other similar taxes and assessments). Report
these taxes on Line 5.5c.

3.2b – State premium taxes
Include:

State premium taxes or State taxes based on policy reserves if in lieu of premium
taxes related to the respective lines of business.

3.2c – Community benefit expenditures deductible from premium in MLR calculations
Federal tax exempt issuers: May report a value for 3.2b and 3.2c. DO NOT enter community
benefit expenditures in excess of the allowable capped amount. Community benefit
expenditures are limited to the highest of either:
1. Three percent of earned premium; or
2. The highest health insurance coverage premium tax rate in the State for which the
report is being submitted, multiplied by the issuer's earned premium in the applicable
State market.
Non-Federal tax exempt issuers: May report a value for 3.2b or 3.2c, but not both. Issuers may
not report zero ($0) community benefit expenditures in lieu of negative State premium taxes.
DO NOT enter community benefit expenditures in excess of the allowable capped amount.
Community benefit expenditures are limited to:
• The highest health insurance coverage premium tax rate in the State for which the
report is being submitted, multiplied by the issuer’s earned premium in the applicable
State market.
If an issuer uses the highest premium tax rate in the State, the issuer must report the applicable
highest State health premium tax rate in Part 6, Line 1.
Note: Issuers must indicate their Federal tax exempt status in the Company Information tab.
**Community benefit expenditures are for activities or programs that seek to achieve the
objectives of improving access to health services, enhancing public health, and relief of
government burden. This includes activities that:
• Are available broadly to the public and serve low-income consumers;
• Reduce geographic, financial or cultural barriers to accessing health services, and if
ceased to exist would result in access problems (e.g., longer wait times or increased
travel distances);
• Address Federal, State or local public health priorities, such as advancing health care
knowledge through education or research that benefits the public;
• Leverage or enhance public health department activities, such as childhood
immunization efforts; or
• Otherwise would become the responsibility of government or another tax-exempt
organization.
Line 3.3 – Regulatory authority licenses and fees
3.3a – Federal Transitional Reinsurance Program Contributions
16

Include:

Federal reinsurance contributions required under Section 1341 of the Affordable
Care Act owed for the MLR reporting year. Report the entire contribution amount,
including contribution amounts allocable to the reinsurance payment pool and
program administrative expense, and to the General Fund of the U.S. Treasury.

3.3b – Other Federal and State regulatory authority licenses and fees incurred by the reporting issuer
during the MLR reporting year
Include:
• Statutory assessments to defray operating expenses of any State or Federal regulatory
authority, including user fees paid to State-based, State Partnership, or Federallyfacilitated Marketplace, risk adjustment user fees, and examination fees in lieu of
premium taxes as specified by State law.
• Amounts paid out to a third party administrator or incurred by or for the issuer in
contraceptive claims costs under the accommodations for self-insured group health
plans of eligible organizations, plus the associated allowance for administrative cost
and margin allowed under 45 CFR 156.50(d)(3)(ii), plus the net Federally Facilitated
Exchange user fee paid to HHS.
Exclude: Fines, penalties, and fees for examinations by any State or Federal regulatory
authority other than as specifically included in Line 3.3.
Section 4 – Health Care Quality Improvement Expenses Incurred
Expenses for Quality Improvement (QI) activities are expenditures directly related to activities conducted
by issuers that are designed to:
• Improve health quality;
• Increase the likelihood of desired health outcomes in ways that are capable of being objectively
measured and of producing verifiable results and achievements;
• Be directed toward individual enrollees or incurred for the benefit of specified segments of
enrollees or provide health improvements to the population beyond those enrolled in coverage as
long as no additional costs are incurred due to the non-enrollees; and
• Be grounded in evidence-based medicine, widely accepted best clinical practice, or criteria issued
by recognized professional medical associations, accreditation bodies, government agencies or
other nationally recognized health care quality organizations.
QI activities must be primarily designed to:
• Improve health outcomes including increasing the likelihood of desired outcomes compared to a
baseline and reduce health disparities among specified populations;
• Prevent hospital readmissions through a comprehensive program for hospital discharge;
• Improve patient safety, reduce medical errors, and lower infection and mortality rates;
• Implement, promote, and increase wellness and health activities; or
• Enhance the use of health care data to improve quality, transparency, and outcomes and support
meaningful use of health information technology consistent with 45 CFR §158.151.
Expenditures and activities that must not be included in quality improving activities are:
• Those that are designed primarily to control or contain costs
17

•
•
•
•

•
•
•
•
•
•
•
•
•

•

The pro rata share of expenses that are for lines of business or products other than those being
reported, including but not limited to, those that are for or benefit self-funded plans
Those which otherwise meet the definitions for quality improvement activities but which were
paid for with grant money or other funding separate from premium revenue
Those activities that can be billed or allocated by a provider for care delivery and which are,
therefore, reimbursed as clinical services
Establishing or maintaining a claims adjudication system, including costs directly related to
upgrades in health information technology that are designed primarily or solely to improve claims
payment capabilities or to meet regulatory requirements for processing claims, including
maintenance of ICD-10 code sets adopted pursuant to the Health Insurance Portability and
Accountability Act (HIPAA), 42 U.S.C. §1320d-2, as amended
That portion of the activities of health care professional hotlines that does not meet the definition
of activities that improve health quality
All retrospective and concurrent utilization review
Fraud prevention activities
The cost of developing and executing provider contracts and fees associated with establishing or
managing a provider network, including fees paid to a vendor for the same reason
Provider credentialing
Marketing expenses
Costs associated with calculating and administering individual enrollee or employee incentives
That portion of prospective utilization that does not meet the definition of activities that improve
health quality
Indirect expenses, such as office space (including rent or depreciation, facility maintenance,
janitorial, utilities, property taxes, insurance, art); computer and telephone usage and equipment;
human resources; compensation of counsel and executives; travel, meals, and entertainment;
company parties and retreats; IT software, systems, mainframes, and other infrastructure, unless
primarily or exclusively supporting QIA; marketing; lobbying; pricing and financial reporting;
vendor profits; other overhead
Any function or activity not expressly included in Lines 4.1 through 4.5, unless otherwise
approved by and within the discretion of the Secretary, upon adequate showing by the issuer that
the activity’s costs support the definitions and purposes in this Part or otherwise support
monitoring, measuring or reporting health care quality improvement

Expenses which otherwise meet the definition for QI activities but which were paid for with grant money
or other funding separate from premium revenues shall NOT be included in QI activities expenses.
Notes:
a.
Healthcare Professional Hotlines: Expenses for healthcare professional hotlines should be
included in Claims Adjustment Expenses to the extent they do not meet the criteria for the above
defined columns of Improve Health Outcomes, Prevent Hospital Readmissions, Improve Patient
Safety, Reduce Medical Errors, and Lower Infection and Mortality Rates, and Implement,
Promote, and Increase Wellness and Health Activities.
b.

Prospective Utilization Review: Expenses for prospective Utilization Review should be included
in Claims Adjustment Expenses to the extent they do not meet the criteria for the above defined
columns of Improve Health Outcomes, Prevent Hospital Readmissions, Improve Patient Safety,
Reduce Medical Errors, and Lower Infection and Mortality Rates, and Implement, Promote, and
Increase Wellness and Health Activities, AND the prospective utilization review activities are not
18

conducted in accordance with a program that has been accredited by a recognized accreditation
body.
Line 4.1 – Improve Health Outcomes
Include expenses directly related to the direct interaction of the insurer (including those
services delegated by contract for which the insurer retains ultimate responsibility under the
insurance policy), providers, and the enrollee or the enrollee’s representatives (e.g., face-toface, telephonic, web-based interactions, or other means of communication) to improve health
outcomes.
This category can include direct costs for associated activities such as:
• Effective case management, care coordination, and chronic disease management,
including through the use of the medical homes model as defined in section 3606 of the
Affordable Care Act
• Accreditation fees by a nationally recognized accrediting entity directly related to
quality of care activities included in Lines 4.1 through 4.5
• Expenses associated with identifying and addressing ethnic, cultural or racial
disparities in effectiveness of identified best clinical practices and evidence based
medicine
• Quality reporting and documentation of care in non-electronic format
Line 4.2 – Activities to Prevent Hospital Readmission
Include expenses directly related to implementing activities to prevent hospital readmissions.
This category can include direct costs for associated activities such as:
• Comprehensive discharge planning (e.g., arranging and managing transitions from one
setting to another, such as hospital discharge to home or to a rehabilitation center) in
order to help assure appropriate care that will, in all likelihood, avoid readmission to
the hospital
• Personalized post discharge counseling by an appropriate health care professional
• Any quality reporting and related documentation in non-electronic form for activities to
prevent hospital readmission
Line 4.3 – Improve patient safety and reduce medical errors
Include expenses directly related to activities primarily designed to improve patient safety,
reduce medical errors, and lower infection and mortality rates.
This category can include direct costs for associated activities such as:
• The appropriate identification and use of best clinical practices to avoid harm
• Activities to identify and encourage evidence based medicine in addressing
independently identified and documented clinical errors or safety concerns
• Activities to lower risk of facility acquired infections
• Prospective prescription drug utilization review aimed at identifying potential adverse
drug interactions

19

•

Any quality reporting and related documentation in non-electronic form for activities
that improve patient safety and reduce medical errors

Line 4.4 – Wellness and health promotion activities
Include expenses directly related to activities primarily designed to implement, promote, and
increase wellness and health activities.
This category can include direct costs for associated activities such as:
• Wellness assessment
• Wellness/lifestyle coaching programs designed to achieve specific and measurable
improvements
• Coaching programs designed to educate individuals on clinically effective methods for
dealing with a specific chronic disease or condition
• Public health education campaigns that are performed in conjunction with state or local
health departments
• Actual rewards/incentives/bonuses/reductions in co-pays, etc. (not administration of
these programs) that are not already reflected in premiums or claims should be allowed
as QI activities for the group market to the extent permitted by section 2705 of the
PHSA
• Any quality reporting and related documentation in non-electronic form for wellness
and health promotion activities
• Coaching or education programs and health promotion activities designed to change
member behavior (e.g., smoking, obesity)
Line 4.5 – Health information technology (HIT) expenses related to improving health care quality
Report information technology expenses associated with the activities in Lines 4.1 through 4.4
for which expenses are reported. (45 CFR §158.151 allows “Health Information Technology”
expenses that are required to accomplish the activities allowed in 45 CFR §158.150.)
Include HIT expenses required to accomplish the activities reported in Lines 4.1 through 4.4
that are designed for use by health plans, health care providers, or enrollees for the electronic
creation, maintenance, access, or exchange of health information as well as activities that are
consistent with Medicare and/or Medicaid meaningful use requirements, and which may in
whole or in part improve quality of care, or provide the technological infrastructure to enhance
current quality improvement or make new quality improvement initiatives possible by doing
one or more of the following:
1. Making incentive payments to health care providers for the adoption of certified
electronic health record technologies and their ‘‘meaningful use’’ as defined by HHS to
the extent such payments are not included in reimbursement for clinical services as
defined in 45 CFR §158.140;
2. Implementing systems to track and verify the adoption and meaningful use of certified
electronic health records technologies by health care providers, including those not
eligible for Medicare and Medicaid incentive payments;
3. Providing technical assistance to support adoption and meaningful use of certified
electronic health records technologies;
20

4. Monitoring, measuring, or reporting clinical effectiveness, including reporting and
analysis of costs related to maintaining accreditation by nationally recognized
accrediting organizations such as NCQA or URAC, or costs for public reporting of
quality of care, including costs specifically required to make accurate determinations of
defined measures (e.g., CAHPS surveys or chart review of HEDIS measures and costs
for public reporting mandated or encouraged by law);
5. Advancing the ability of enrollees, providers, issuers or other systems to communicate
patient centered clinical or medical information rapidly, accurately, and efficiently to
determine patient status, avoid harmful drug interactions or direct appropriate care –
this may include electronic health records accessible by enrollees and appropriate
providers to monitor and document an individual patient’s medical history and to
support care management;
6. Tracking whether a specific class of medical interventions or a bundle of related
services leads to better patient outcomes;
7. Reformatting, transmitting or reporting data to national or international governmentbased health organizations for the purposes of identifying or treating specific
conditions or controlling the spread of disease; or
8. Provision of electronic health records, patient portals, and tools to facilitate patient
self-management.
Exclude costs associated with establishing or maintaining a claims adjudication system,
including costs directly related to upgrades in HIT that are designed primarily or solely to
improve claims payment capabilities or to meet regulatory requirements for processing claims
(for example, costs of implementing new administrative simplification standards and code sets
adopted pursuant to the Health Insurance Portability and Accountability Act (HIPAA), 42
U.S.C. §1320d-2, as amended, including all expenditures related to ICD-10).
Line 4.6 – Total allowable quality improvement expenses
Part 1, Lines 4.1 + 4.2 + 4.3 + 4.4 + 4.5
Section 5 – Non-Claims Costs
Line 5.1 – Cost containment expenses not included in quality improvement expenses
Include:

Expenses that serve to actually reduce the number of health services provided or
the cost of such services.

This category can include costs only if they result in reduced costs or services such as:
• Post- and concurrent- claim case management activities associated with past or
ongoing care
• Pre-service utilization review
• Detection and prevention of payment for fraudulent requests for reimbursement
(including amounts reported in Part 2, Line 2.17a)
• Expenses for internal and external appeals
• Network access fees to preferred provider organizations and other network-based
health plans (including prescription drug networks) and allocated internal salaries and
related costs associated with network development and/or provider contracting
21

Exclude: Cost-containment expenses that improve the quality of health care reported in Part
1, Section 4.
Line 5.2 – All other claims adjustment expenses
Include any expenses for administrative services that do not constitute adjustments to premium
revenue, reimbursement for clinical services to enrollees or expenditures on quality
improvement activities or cost containment expenses.
This category can include such costs as:
• Estimating the amount of losses and disbursing loss payments
• Maintaining records, general clerical and secretarial costs
• Office maintenance, occupancy costs, utilities, and computer maintenance
• Supervisory and executive duties
• Supplies and postage
• Interest or other payments made in accordance with prompt payment laws or
regulations to claimants. (Interest or penalties paid to regulatory authorities are
reported as regulatory fines and fees.)
Line 5.3 – Direct sales salaries and benefits
Include compensation (including but not limited to salary and benefits) to employees engaged
in soliciting and generating sales to policyholders for the issuer.
Line 5.4 – Agents and brokers fees and commissions
All expenses incurred by the issuer payable to a licensed agent, broker, or producer who is not
an employee of the issuer in relation to the sale and solicitation of policies for the company.
Line 5.5 – Other taxes
5.5a – Taxes and assessments not excluded from premium. (Do not include amounts reported in
Section 3 or Lines 5.5c or 9.)
Include:
• Taxes and assessments not deducted from Premium in Section 3
• State sales taxes if the issuer does not exercise the option of including such taxes with
the cost of goods sold and services purchased
• Any portion of commissions or allowances on reinsurance assumed that represent
specific reimbursement of premium taxes
• Any portion of commissions or allowances on reinsurance ceded that represents
specific reimbursement of premium taxes
5.5b – Fines and penalties of regulatory authorities, and fees for examinations by any State or Federal
departments other than those included in Line 3.3b, above. Interest, penalty, or other payments
made in accordance with prompt payment laws or regulations to regulatory authorities.
5.5c – Federal and State employment taxes and assessments
22

Include:

Federal and State employment taxes and assessments (such as the Federal
Insurance Contributions Act (FICA), the Railroad Retirement Tax Act (RRTA),
and the Federal Unemployment Act (FUTA) taxes; State unemployment /
reemployment insurance and State employment training taxes; and other similar
taxes and assessments)

Line 5.6 – Other general and administrative expenses
Include:

General and Administrative Expenses not previously reported in Sections 3, 4, or 5
above.

These expenses include such examples as:
• Salaries
• Outsource services
• EDP equipment, other equipment
• Accreditation and certification fees
• Reimbursement by uninsured plans and fiscal intermediaries
• ICD-10 costs
• Community benefit expenditures – report only the amount in excess of what is already
reported in Part 1, Line 3.2c
• Other additional expenses not included in another category such as rent, legal fees and
expenses, medical examination expenses, inspection reports, professional consulting
fees, travel, advertising, postage, utilities, etc.
• Services provided by affiliates under management agreements
• Rating agencies and other similar organizations
• Prescription drug rebates and other price concessions received by an entity providing
pharmacy benefit management services (including drug price negotiation services) to
the issuer to the extent the amounts are associated with administering the issuer's
prescription drug benefits).
Exclude: Any elements already reported on Lines 5.1, 5.2, 5.3, 5.4, and 5.5
Line 5.7 – Total community benefit expenditures (informational only; include amounts reported in Lines
3.2c and 5.6)
Section/Line 6 – Income from fees on uninsured plans
Section 7 – Other indicators or information
Line 7.1 – Number of policies/certificates
In the individual market, this is the number of individual policies, not counting dependents, in
force as of the last day of the reporting year.
In the group markets, this is the number of certificates issued to individuals covered under a
group policy in force as of the last day of the reporting year (e.g. number of employees, NOT
counting dependents). It is NOT the number of group policyholders (e.g. employers).
23

Reasonable approximations are allowed when exact information is not available to the issuer
for group business.
Line 7.2 – Number of covered lives
This is the total number of lives insured, including dependents, under individual policies and
under group certificates as of the last day of the reporting year. Reasonable approximations are
allowed when exact information is not available to the issuer.
Line 7.3 – Number of groups
Applicable to the group markets only. This is the total number of employer groups insured as
of the last day of the reporting year. This is NOT the number of certificates, employees,
covered lives, or life-years.
Line 7.4 – Member months
The total number of lives, including dependents, insured on a pre-specified day of each month
of the reporting period. Reasonable approximations are allowed when exact information is not
available to the issuer.
Line 7.5 – Number of life-years
Part 1, Line 7.4 / 12
Section 8 – Net investment income and other gain/ (loss)
Enter the Grand Total as of 12/31 for ALL markets in Columns 1–43 of each State filing.
Section 9 – Other Federal income taxes
Enter the Grand Total as of 12/31 for ALL markets in Columns 1–43 of each State filing.
Include: Federal income taxes on investment income and capital gains.
Exclude: Taxes entered on Part 1, Lines 3.1a-d.

24

Instructions for MLR Annual Reporting Form − Part 2
(Premium and Claims)
These MLR Form Filing Instructions apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions may be revised to reflect changes that apply to the filing years
subsequent to 2022.
In addition to the instructions below, the General Instructions and Column Definitions at the beginning of
these Filing Instructions apply to Part 2. The General Instructions and Column Definitions include
instructions regarding reporting of reinsurance, deferred business, individual business through an
association, employer business through a group trust or MEWA, group coverage in multiple States, and
dual contract group health coverage.
Please note that the MLR Form and Filing Instructions implement the requirements of 45 CFR Part 158
and are not identical to the definitions or instructions of the NAIC’s SHCE.
Section 1 – Health Premiums Earned
Earned premium means all monies paid by a policyholder or subscriber as a condition of receiving
coverage from the issuer, including any fees or other contributions associated with the health plan and
reported on a direct basis. Include advance payments of the premium tax credit. Any amounts for ACA
fees collected in advance of the MLR reporting year in which the fee is payable must not be reported as
unearned premium.
Line 1.1 – Direct premium written
12/31 Column – report amount as of 12/31 of the MLR reporting year, as reported to the
regulatory authority in the issuer’s State of domicile or as filed on the NAIC SHCE filing
for the MLR reporting year.
3/31 Column (premium for coverage in MLR reporting year only) – report premium collected
from 1/01 of the MLR reporting year through 3/31 of the year following the MLR
reporting year for coverage in the MLR reporting year only, plus uncollected (due and
unpaid) premium for coverage in the MLR reporting year only as of 3/31 of the year
following the MLR reporting year. Premium should reflect retroactive eligibility
adjustments related to coverage in the MLR reporting year.
PLEASE NOTE: This methodology differs from NAIC SHCE methodology. However,
issuers may choose to report amounts on the same basis as in the 12/31 columns, except
that risk adjustment amounts must not be reflected in the 3/31 columns.
Premium should include all amounts collected toward ACA fees, regardless of whether the
fees were included in premium or billed as a separate line item.

25

Include:
• Premium assumed under a 100% assumption reinsurance agreement (with a novation) must
be reported by the assuming issuer for the entire MLR reporting year during which the
policies are assumed and must not be reported by the ceding issuer
• Premium assumed under a 100% indemnity reinsurance and administrative agreement,
limited to only those agreements both entered into and also effective prior to March 23,
2010, where the assuming entity is responsible for 100% of the ceding entity’s financial
risk and takes on all of the administration of the block of business
Exclude:
• Premium ceded under a 100% assumption reinsurance agreement (with a novation) must
be reported by the assuming issuer for the entire MLR reporting year during which the
policies are assumed and must not be reported by the ceding issuer
• Premium ceded under a 100% indemnity reinsurance and administrative agreement,
limited to only those agreements both entered into and also effective prior to March 23,
2010, where the assuming entity is responsible for 100% of the ceding entity’s financial
risk and takes on all of the administration of the block of business
• Assessments paid to or subsidies received from State high risk pools
• Amounts for rate credits paid or received (these amounts must be reported separately on
Part 2, Lines 1.4-1.6 and 2.8-2.10)
• In the 3/31 columns, exclude risk adjustment transfer amounts and accruals
Line 1.2 – Unearned premium (year preceding the MLR reporting year)
12/31 Column – report reserves established to account for the portion of the premium paid prior to
the MLR reporting year that was intended to provide coverage during the MLR reporting
year. Report reserves as of 12/31 of the year preceding the MLR reporting year, as
reported to the regulatory authority in the issuer’s State of domicile or as filed on the
NAIC SHCE filing for the year preceding the MLR reporting year.
3/31 Column (premium for coverage in the MLR reporting year only) – report premium for
coverage in the MLR reporting year only, collected in the immediately preceding MLR
reporting year. Report amounts as of 12/31 of the year preceding the MLR reporting year.
PLEASE NOTE: This methodology differs from NAIC SHCE methodology. However, if
the issuer chose to report direct written premium in Line 1.1 on the same basis as in the
12/31 column, the issuer should report unearned premium reserves consistently with how it
reports direct written premium. Do not include any risk adjustment transfer amounts or
accruals.
Line 1.3 – Unearned premium (MLR reporting year)
12/31 Column – report reserves established to account for the portion of the premium paid in the
MLR reporting year that was intended to provide coverage during the following MLR
reporting year. Report reserves as of 12/31 of the MLR reporting year, as reported to the
regulatory authority in the issuer’s State of domicile or as filed on the NAIC SHCE filing
for the MLR reporting year.

26

3/31 Column – report zero (note that if collected and due and unpaid premium is reported correctly
in Line 1.1 above, Line 1.1 should not include amounts that would constitute unearned
premium for coverage in years subsequent to the MLR reporting year).
PLEASE NOTE: This methodology differs from the NAIC SHCE methodology. However,
if the issuer chose to report direct written premium in Line 1.1 on the same basis as in the
12/31 column, the issuer should report unearned premium reserves consistently with how it
reports direct written premium. Do not include any amounts collected during 2019 for
2020 ACA fees as unearned premium. Do not include any risk adjustment transfer amounts
or accruals.
Line 1.4 – Experience rating refunds (rate credits) paid or received
1.4a – 12/31 Column – report all refunds paid or received through 12/31 of the MLR reporting
year.
1.4b – 3/31 Column – report refunds associated only with claims incurred during the MLR
reporting year, paid or received through 3/31 of the following year.
Include:

Experience rating refunds and State premium refunds paid or received during the MLR
reporting year. Experience rating refund is the return of a portion of premium pursuant
to a retrospectively rated funding arrangement when the sum of incurred losses,
retention, and margin are less than earned premium.

Exclude: Federal and State MLR rebates, and risk corridors payments or charges.
Line 1.5 – Reserves for experience rating refunds (MLR reporting year)
12/31 Column – all refunds unpaid as of 12/31 of the MLR reporting year.
3/31 Column –refunds associated only with claims incurred during the MLR reporting year, not
paid or received through 3/31 of the following year.
Include:

Reserves for experience rating refunds, plus reserves for State premium refunds.

Exclude: Reserves for Federal and State MLR rebates, premium stabilization reserves, and risk
corridors reserves or accruals.
Deduct:

Amounts receivable under retrospectively rated funding arrangements.

Line 1.6 – Reserves for experience rating refunds (year preceding the MLR reporting year)
12/31 Column – as of 12/31 of the year preceding the MLR reporting year.
See instructions for Line 1.5.
Line 1.7 – Premium write-offs
Include:
27

•
•
•

Agents’ or premium balances determined to be uncollectible and written off as losses
Recoveries made during the MLR reporting year on balances previously written off
Include actual write-offs

Exclude:
• Reserves for bad debt or statutory non-admitted amounts
Line 1.8 – Group conversion charges
If the amount entered on Line 1.1 has been reduced or increased by the amount of any conversion
charges associated with group conversion privileges between Group and Individual lines of
business in your annual statement accounting, enter the reverse of these charges on this line in the
appropriate columns.
•

•

If an issuer transfers portions of earned premium associated with group conversion
privileges between group and individual lines of business in its Annual Statement, these
amounts must be added to or subtracted from incurred claims. (See Part 2, Section 2 –
Claims.)
If an issuer has only group lines of business and no other individual market experience, the
issuer may choose to report the experience of the group conversion policies in the columns
for the applicable group market, rather than the individual market columns, and leave this
line blank.

Line 1.9 – Federal Transitional Reinsurance Program Payments
Include adjustments to amounts for prior benefit years, if not previously reported on an MLR
Form for a prior MLR reporting year.
Line 1.10 – Federal Risk Adjustment Program Net Receipts or Charges
3/31 Column –
Include:
• Expected net payments from HHS (enter as a positive amount) or charges payable to HHS
(enter as a negative amount), as shown on the notification received from HHS by June 30
of the year following the MLR reporting year (unless instructed otherwise by HHS)
• Risk adjustment default charges or default charge allocation amounts, if any
• Amounts related to the high-cost risk pools, if any (the HCRP charge amounts can be
obtained from the HRPICR report in the EDGE Management Console in HIOS)
• Adjustments to amounts for prior benefit years, if not previously reflected on an MLR
Form for a prior MLR reporting year, except as noted below (unless instructed otherwise
by HHS)
• HHS-Risk Adjustment Data Validation (HHS-RADV) adjustments and default data
validation charges and allocations for the benefit year(s) specified in the table below.
Do not include any estimates of the 2022 benefit year HHS-RADV adjustments or 2022 benefit
year default data validation charges and allocations.

28

The following table explains which benefit years of risk adjustment and HHS-RADV adjustments
should be reported in which MLR reporting years for the 2020-2025 reporting years:
MLR Reporting Year RA Benefit Year to Include RADV Benefit Year(s) to Include
2020 (Filed in 2021)
2020
None
2021 (Filed in 2022)
2021
2017
2022 (Filed in 2023)
2022
2018, 2019, 2020, 2 2021
2023 (Filed in 2024)
2023
2022
2024 (Filed in 2025)
2024
2023
2025 (Filed in 2026)
2025
2024

Line 1.11 – Reserved
Line 1.12 – Premium ceded under 100% reinsurance (informational only; excluded from Line 1.1)
Include:
• Premium ceded under a 100% assumption reinsurance agreement (with a novation)
• Premium ceded under a 100% indemnity reinsurance and administrative agreement,
limited to only those agreements both entered into and also effective prior to March 23,
2010, where the assuming entity is responsible for 100% of the ceding entity’s financial
risk and takes on all of the administration of the block of business
Line 1.13 – Premium assumed under 100% reinsurance agreement (informational only; included in Line
1.1)
Include:
• Premium assumed under a 100% assumption reinsurance agreement (with a novation)
• Premium assumed under a 100% indemnity reinsurance and administrative agreement,
limited to only those agreements both entered into and also effective prior to March 23,
2010, where the assuming entity is responsible for 100% of the ceding entity’s financial
risk and takes on all of the administration of the block of business
Line 1.14 – Advance Payments of the Premium Tax Credit Received from HHS (informational only;
included in Lines 1.1-1.11)
Include:

Amount of advance premium tax credit received from HHS for the applicable benefit
year (MLR reporting year).

Section 2 – Claims
Amounts reported in Section 2 must include direct claims paid to or received by physicians and other nonphysician clinical providers, including under capitation contracts with those providers, whose services are
covered by the policy for clinical services or supplies covered by the policy. Non-physician clinical
providers must be licensed, accredited, or certified to perform clinical health services, consistent with
State law, and engaged in the delivery of medical services to enrollees.
Reimbursement for clinical services to enrollees is also referred to as incurred claims.
See the Delaying Release of 2020 Benefit Year HHS Risk Adjustment Data Validation Results memo released on June 21,
2022 at https://www.cms.gov/files/document/2020-hhs-radv-delaying-results.pdf.

2

29

When a pharmacy benefit manager (PBM) pays a retail pharmacy one amount for prescription drugs
covered by the plan and charges the issuer a higher amount (sometimes called the spread), the issuer may
only include in its incurred claims the amounts paid by the PBM to the retail pharmacy, and may not
include the entire amount the issuer paid to the PBM.
PLEASE NOTE: The relationship between the claim liability reported in the 3/31 Column and the paid
claims reported in Line 2.1b should, on average, be consistent with the actual claims run-out following the
three immediately preceding reporting years. While issuers may appropriately estimate the components
of the incurred claims, such as liabilities, conservatively for State financial reporting purposes, claims
liabilities, reserves, and other components for MLR purposes should be the most accurate estimate of
actual payments, and therefore should not be consistently overestimated, including due to the use of
conservative margins for adverse deviation.
Line 2.1 – Claims paid
2.1a – 12/31 Column – claims paid during the MLR reporting year regardless of incurred date.
2.1b – 3/31 Column – claims incurred only during the MLR reporting year, paid from 1/01 of the
MLR reporting year through 3/31 of the following year. Do not reduce paid claims by the
amount of reinsurance receipts. State reinsurance receipts are reported on Line 2.16 and
subtracted from incurred claims in Line 2.17, below. Federal reinsurance receipts are
subtracted from incurred claims in Part 3.
PLEASE NOTE: This methodology differs from the NAIC SHCE methodology used in the
12/31 Column.
Include:
• Report payments net of risk share amount collected or paid
• Any overpayment that has not yet been recovered should be included in paid claims and
included in health care receivables
• Market stabilization payments by issuers that are directly tied to claims incurred and other
claims based or census based assessments
• Claims assumed under a 100% assumption reinsurance agreement (with a novation) must
be reported by the assuming issuer for the entire MLR reporting year during which the
policies are assumed and must not be reported by the ceding issuer
• Claims assumed under a 100% indemnity reinsurance and administrative agreement,
limited to only those agreements both entered into an effective prior to March 23, 2010,
where the assuming entity is responsible for 100% of the ceding entity’s financial risk and
takes on all of the administration of the block of business
• Payment to unsubsidized State programs designed to address distribution of health risks
across issuers via charges to low risk issuers that are distributed to high risk issuers must
be included in incurred claims
• Payment by a group health insurance issuer for contraceptive services for participants and
beneficiaries of its insured health plans under the accommodations for eligible
organizations
• In the 3/31 columns, include all payments by a QHP issuer to enrollees in all plan
variations, and do not reduce these payments by the amount of cost-sharing reductions
30

(CSR) received by the issuer for the applicable benefit year (MLR reporting year). CSRs
are subtracted from incurred claims in Part 3.
Exclude:
• Claims ceded under a 100% assumption reinsurance agreement (with a novation) must be
reported by the assuming issuer for the entire MLR reporting year during which the
policies are assumed and must not be reported by the ceding issuer
• Claims ceded under a 100% indemnity reinsurance and administrative agreement, limited
to only those agreements both entered into an effective prior to March 23, 2010, where the
assuming entity is responsible for 100% of the ceding entity’s financial risk and takes on
all of the administration of the block of business
• Amounts paid to third party vendors, including PBMs, for secondary network savings
• Amounts paid to third party vendors, including PBMs, for network development,
administrative fees and profit, claims processing, and concurrent or post-service utilization
management or any other issuer function
• Amounts paid, including amounts paid to a provider, for professional or administrative
services that do not represent compensation or reimbursement for covered services
provided to an enrollee
• Incentive and bonus payments made to providers (to be reported in Line 2.11)
• Late claims payment interest or penalty; report these amounts in Part 1, Lines 5.2 and 5.5b,
as appropriate
Deduct:
• State subsidies based on a stop-loss payment methodology, other than receipts from State
reinsurance programs reported on Line 2.16
• Any overpayment that has already been received from providers should not be reported as
a paid claim
• Prescription drug rebates and other price concessions that decrease the costs of a
prescription drug covered by the issuer, including rebates, refunds, incentive payments,
bonuses, discounts, charge backs, free goods contingent on a purchase agreement, free or
reduced-price services, coupons, grants, upfront payments, goods in kinds, or similar
benefits, to the extent the value of these items is not passed on to the enrollee, and
excluding bona fide service fees. This includes amounts received by the issuer, as well as
amounts received by an entity providing pharmacy benefit management services (including
drug price negotiation services) to the issuer to the extent the amounts are associated with
administering the issuer's prescription drug benefits.
• Market stabilization receipts by issuers that are directly tied to claims incurred and other
claims based or census based assessments
• Payment from unsubsidized State programs designed to address distribution of health risks
across issuers via charges to low risk issuers that are distributed to high risk issuers must
be deducted from incurred claims
Line 2.2 – Direct claim liability (MLR reporting year)
2.2a – 12/31 Column – liability as of 12/31 of MLR reporting year for all claims regardless of
incurred date.

31

2.2b – 3/31 Column – liability based on claims incurred only during the MLR reporting year, and
unpaid as of 3/31 of the following year.
Include:
• Unpaid claims, including claims reported in the process of adjustment, percentage
withholds from payments made to contracted providers, recoverable for anticipated
coordination of benefits (COB) and subrogation (including third party liability)
• Incurred but not reported – report claims incurred only during the MLR reporting year and
not reported by 3/31 of the following year. Except where inapplicable, the reserve
included in these lines should be based on past experience, modified to reflect current
conditions, such as changes in exposure
Line 2.3 – Direct claim liability prior year (year preceding the MLR reporting year)
12/31 Column – liability as of 12/31 of the year preceding the MLR reporting year, as reported to
the regulatory authority in the issuer’s State of domicile or as reported on the NAIC SHCE
filing for the year preceding the MLR reporting year.
Line 2.4 – Direct claim reserves (MLR reporting year)
2.4a – 12/31 Column – reserves as of 12/31 of MLR reporting year for all claims regardless of
incurred date.
2.4b – 3/31 Column – reserves based on experience incurred only in the MLR reporting year,
calculated as of 3/31 of the following year.
Report reserves related to healthcare services for present value of amounts not yet due on claims.
Line 2.5 – Direct claim reserves prior year (year preceding the MLR reporting year)
12/31 Column – reserves as of 12/31 of the year preceding the MLR reporting year, as reported to
the regulatory authority in the issuer’s State of domicile or as reported on the NAIC SHCE
filing for the year preceding the MLR reporting year.
Line 2.6 – Direct contract reserve (MLR reporting year)
Report the amount of reserves required when, due to the gross premium structure, the future
benefits exceed the future net premium. Contract reserves are in addition to claim liabilities and
claim reserves.
Include:

Contract reserves and other claims related reserves.

Exclude: Premium deficiency reserves.
Reserves for expected MLR rebates.
2.6a – 12/31 Column – reserves as of 12/31 of the MLR reporting year, as reported to the
regulatory authority in the issuer’s State of domicile or as reported on the NAIC SHCE
filing for the MLR reporting year.
32

2.6b – 3/31 Column – for policies issued prior to 2011, contract reserves may only be used in the
MLR calculation if such reserves were held prior to 2011, and may include reserves used
for the purpose of leveling policy duration-based variation in claims experience only if
durational contract reserves were held for such policies prior to 2011. Reported contract
reserves may not exceed contract reserves calculated using the applicable product pricing
assumptions. Calculate as of 12/31 of the MLR reporting year.
Line 2.7 – Direct contract reserves prior year (year preceding the MLR reporting year)
12/31 Column – amount reported as of 12/31 of the year preceding the MLR reporting year.
3/31 Column – amount reported on Line 2.6b in the 3/31 Column of the MLR Form for the
preceding year.
Line 2.8 – Experience rating refunds (rate credits) paid or received
2.8a – 12/31 Column – report all refunds paid or received through 12/31 of the MLR reporting
year.
2.8b – 3/31 Column – report refunds associated only with claims incurred during the MLR
reporting year, paid or received through 3/31 of the following year.
Include:

Experience rating refunds and State premium refunds paid or received during the MLR
reporting year. Experience rating refund is the return of a portion of premium pursuant
to a retrospectively rated funding arrangement when the sum of incurred losses,
retention, and margin are less than earned premium.

Exclude: Federal and State MLR rebates, and risk corridors payments or charges.
Line 2.9 – Reserves for experience rating refunds (MLR reporting year)
2.9a – 12/31 Column – all refunds unpaid as of 12/31 of the MLR reporting year.
2.9b – 3/31 Column – refunds associated only with claims incurred during the MLR reporting
year, not paid or received as of 3/31 of the following year.
Include:

Reserves for experience rating refunds, plus reserves for State premium refunds.

Exclude: Reserves for Federal and State MLR rebates, premium stabilization reserves, and risk
corridors reserves or accruals.
Deduct:

Amounts receivable under retrospectively rated funding arrangements.

Line 2.10 – Reserves for experience rating refunds (year preceding the MLR reporting year)
12/31 Column – as of 12/31 of the year preceding the MLR reporting year.
See instructions for Line 2.9.
33

Line 2.11 – Incurred medical incentive pools and bonuses
12/31 Column – based on all payments or receipts through 12/31 of the MLR reporting year.
3/31 Column – based on amounts incurred only for the MLR reporting year and paid or received
through 3/31 of the following year.
Include:

Arrangements with providers and other risk sharing arrangements whereby the
reporting entity agrees to either share savings or make incentive payments or receipts
to providers. Include only incentive and bonus payments made to providers that are
tied to clearly-defined, objectively measurable, and well-documented clinical or quality
improvement standards that apply to providers.

2.11a – Paid or received medical incentive pools and bonuses for the MLR reporting year.
2.11b – Accrued medical incentive pools and bonuses for the MLR reporting year. Exclude
amounts recorded on Line 2.11a, include only the amount of medical incentive and bonus
pool payments or receipts that are estimated to be owed but not yet paid or received for the
MLR reporting year.
2.11c – Accrued medical incentive pools and bonuses for the year preceding the MLR reporting
year.
Line 2.12 – Net healthcare receivables
12/31 Column – receivables reported as of 12/31 of the MLR reporting year.
3/31 Column – receivables incurred during the MLR reporting year and that remain outstanding as
of 3/31 of the following year.
2.12a – Healthcare receivables (MLR reporting year).
2.12b – Healthcare receivables (year preceding the MLR reporting year).
The amounts on these lines are the gross healthcare receivable assets, not just the admitted portion.
These amounts should not include those healthcare receivables, such as loans or advances to nonrelated party hospitals, established as prepaid assets that are not expensed until the related claims
have been received from the provider. These amounts should include prescription drug rebates and
other price concessions receivables.
Line 2.13 – Contingent benefit and lawsuit reserves for claims incurred in the MLR reporting year
12/31 Column – reserves as of 12/31 of the MLR reporting year.
If not separately reported in annual financial filings to the issuer’s regulatory authority, the
issuer does not need to separately report this element in this column.
3/31 Column – reserves related to claims incurred during the MLR reporting year and unpaid as of
3/31 of the following year.
34

Issuer must separately report this data element in the 3/31 column as provided in 45 CFR
Part 158 and as noted in the General Instructions.
Include:

The claims-related portion of reserves for contingent benefits and lawsuits.

Exclude: Reserves related to costs associated with claims lawsuits within Line 2.13; e.g., legal
fees, court costs, pain and suffering damages, punitive damages, etc.
Line 2.14 – Group conversion charges
If there are any group conversion charges for a health plan, the conversion charges must be
subtracted from the incurred claims for the aggregation that includes the conversion policies and
this same amount must be added to the incurred claims for the aggregation that provides coverage
that is intended to be replaced by the conversion policies.
If an issuer transfers portions of earned premium associated with group conversion privileges
between group and individual lines of business in its annual statement accounting, these amounts
must be added to or subtracted from incurred claims.
If an issuer has only group lines of business and no other individual market experience, the issuer
may choose to report the experience of the group conversion policies in the columns for the
applicable group market, rather than the individual market columns, and leave this line blank.
Line 2.15 – Blended rate adjustment
Affiliated issuers that offer group coverage at a blended rate may choose whether to make an
adjustment to each affiliate’s incurred claims and activities to improve health care quality, to
reflect the experience of the issuer with respect to the employer as a whole, according to an
objective formula the issuer defined prior to the beginning of the MLR reporting year, so as to
result in each affiliate having the same ratio of incurred claims to earned premium for that
employer group for the MLR reporting year as the ratio of incurred claims to earned premium
calculated for the employer group in the aggregate. From the date an issuer chooses to use such
an adjustment, it must be used for a minimum of three consecutive MLR reporting years.
Affiliated issuers that choose to make such an adjustment must do so for all policies with blended
rates in the applicable State market.
Line 2.16 – State Reinsurance Program Payments
Include:

Expected Receipts from State Reinsurance Programs 3

For example, receipts from the Alaska Reinsurance Program, Colorado Health Insurance Affordability Enterprise,
Connecticut Small Employer Health Reinsurance Pool, Delaware Health Insurance Individual Market Stabilization
Reinsurance Program & Fund, Maine Guaranteed Access Reinsurance Association, Maryland Reinsurance Program,
Minnesota Premium Security Plan, Montana Reinsurance Program, New Hampshire Reinsurance Program, New Jersey
Reinsurance Program, Reinsurance Association of North Dakota, Oregon Reinsurance Program, Pennsylvania Commonwealth
Health Insurance Reinsurance Program, Rhode Island Reinsurance Program, Wisconsin Healthcare Stability Plan, and receipts
from other State reinsurance programs, including those established under Section 1332 of the Patient Protection and Affordable
Care Act.

3

35

NOTE: Report contributions to State Reinsurance Programs, regardless of the form of
contribution, in Part 1, Line 3.2a
Line 2.17 – Total incurred claims
12/31 Column – Part 2, Lines 2.1a + 2.2a – 2.3 + 2.4a – 2.5 + 2.6a – 2.7 + 2.8a + 2.9a – 2.10 +
2.11a + 2.11b – 2.11c – 2.12a + 2.12b + 2.13 + 2.14 + 2.15 – 2.16
3/31 Column – Part 2, Lines 2.1b + 2.2b + 2.4b + 2.6b – 2.7 + 2.8b + 2.9b + 2.11a + 2.11b – 2.12a
+ 2.13 + 2.14 + 2.15 – 2.16
(Note: Allowable fraud reduction expenses are added to Incurred Claims in the calculation of
Adjusted Incurred Claims in Part 3, Line 1.2.)
Line 2.18 – Allowable claims recovered through fraud reduction efforts
Report the amount of claims payments recovered through fraud reduction efforts not to exceed the
amount of fraud reduction expenses.
This amount is limited to the lesser of the total fraud reduction expenses reported on Line 2.18a or
the actual fraud recoveries collected on paid claims on Line 2.18b. If either Line 2.18a or Line
2.18b is equal to zero (0) then the allowable amount is equal to zero (0).
2.18a – Total fraud reduction expense.
2.18b – Total fraud recoveries that reduced PAID claims in Part 2, Line 2.1.
Include collected fraud recoveries on paid claims only.
Line 2.19 – Reconciled Payments of Cost-sharing Reductions
Include:

Total reconciled cost-sharing reductions amount for the MLR reporting year, including
from State CSR programs

36

Instructions for MLR Annual Reporting Form − Part 3
(MLR and Rebate Calculation)
These MLR Form Filing Instructions apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions may be revised to reflect changes that apply to the filing years
subsequent to 2022.
No data should be entered in any of the cells shaded grey.
COLUMN DEFINITIONS – PART 3
Columns 1, 5, 9, 13, 17, 21, 33 – PY2
Report the information for the MLR reporting year that is 2 years prior to the MLR reporting year.
Report corrected amounts if reported in error in prior MLR Form submissions. All elements
should be reported in accordance with the applicable reporting year’s instructions. Exception: Line
1.1 should be reported as originally submitted.
Columns 2, 6, 10, 14, 18, 22, 34 – PY1
Report the information for the MLR reporting year that is 1 year prior to the MLR reporting year.
Report corrected amounts if reported in error in prior MLR Form submissions. All elements
should be reported in accordance with the applicable reporting year’s instructions. Exception: Line
1.1 should be reported as originally submitted.
Columns 3, 7, 11, 15, 19, 23, 35 – CY
Report the information for the MLR reporting year.
Columns 4, 8, 12, 16, 20, 24, 36 – Total
For Sections 1 and 2 and Line 4.1, report the sum of the amounts in PY2, PY1, and CY columns,
except for Lines 1.9 and 2.3. Otherwise, follow line instructions. The Total column is used to
calculate the numerator and denominator of the MLR calculation. CY adjusted premium is used to
calculate the issuer’s rebate, if any.
Column Groupings
For the definitions for each of the following markets, see the Column Definitions at the beginning of these
Filing Instructions.
Columns 1–4
Columns 5–8
Columns 9–12
Columns 13–16
Columns 17–20
Columns 21–24
Columns 25–28
Columns 29–32

–
–
–
–
–
–
–
–

Individual Market
Small Group Market
Large Group Market
Mini-Med plans – Individual Market
Mini-Med plans – Small Group Market
Mini-Med plans – Large Group Market
Expatriate plans – Small Group Market (Not applicable for 2022)
Expatriate plans – Large Group Market (Not applicable for 2022)
37

Columns 33–36

– Student Health plans – Individual Market (GT template only)

LINE INSTRUCTIONS – PART 3
Columns 1–24 are not applicable for the GT template and may be left blank.
Section 1 – Medical Loss Ratio Numerator
Line 1.1 – Adjusted incurred claims as reported on the MLR Form for prior year(s)
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 3, Line 1.2, Column CY
Line 1.2 – Adjusted incurred claims as of 3/31 of the year following the MLR reporting year
Report corrected amounts if prior year’s information was reported inaccurately.
PY2 Column – enter the amount of adjusted incurred claims reported on Part 3, Line 1.2, Column
CY of the MLR Form 2 years prior to the MLR reporting year, restated as of 3/31 of the
year following the MLR reporting year. For example, for reporting year 2022, the issuer
would enter 2020 adjusted incurred claims restated as of 3/31/2023. (This is also known as
claims incurred in 12 months and paid in 39 months.) Restate all applicable elements of
adjusted incurred claims, including reserves and the allowable claims recovered through
fraud reduction efforts, in accordance with the Filing Instructions from 2 years prior to the
MLR reporting year.
PY1 Column – enter the amount of adjusted incurred claims reported on Part 3, Line 1.2, Column
CY of the MLR Form for the preceding MLR reporting year, restated as of 3/31 of the year
following the MLR reporting year. (This is also known as claims incurred in 12 months
and paid in 27 months). Restate all applicable elements of adjusted incurred claims,
including reserves and the allowable claims recovered through fraud reduction efforts, in
accordance with the Filing Instructions from the year preceding the MLR reporting year.
CY Column – Part 1, Lines 2.1 + 2.11, Columns 3/31 + Deferred PY1 – Deferred CY (Note that
adjusted incurred claims in the Deferred PY1 columns on Parts 1 and 2 should have been
restated as of 3/31 of the year following the MLR reporting year.)
Line 1.3 – Improving Health Care Quality Expenses
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 3, Line 1.3, Column CY
CY Column – Part 1, Line 4.6, Columns 3/31 + Deferred PY1 – Deferred CY
Line 1.4 – Reconciled Payments of Cost-Sharing Reductions
PY2 and PY1 Columns – Amount of reconciled cost-sharing reductions for 2020 and 2021,
respectively.
CY Column – Part 2, Line 2.19, Columns 3/31 + Deferred PY1 – Deferred CY
38

Line 1.5 – Federal Transitional Reinsurance Program payments
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 3, Line 1.5, Column CY
CY Column – Part 2, Line 1.9, Columns 3/31 + Deferred PY1 – Deferred CY
Line 1.6 – Net Federal Risk Adjustment Program payments or charges
See instructions for Part 2, Line 1.10 for the mapping of the HHS-RADV adjustments and MLR
reporting years.
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 3, Line 1.6, Column CY
CY Column – Part 2, Line 1.10, Columns 3/31 + Deferred PY1 – Deferred CY
Line 1.7 – Reserved
Line 1.8 – Shared Savings payments to enrollees
Shared savings payments made by the issuer to an enrollee as a result of the enrollee choosing to
obtain health care from a lower-cost, higher-value provider.
Line 1.9 – MLR numerator
All Columns – Lines 1.2 + 1.3 – 1.4 – 1.5 – 1.6 + 1.8
In states with different MLR standards for the current reporting year or either of the two prior
years, issuers may scale the experience included in the Total column for Line 1.9 to account
for the change(s) in MLR standards. The scaling adjustment for the prior year is the current
year standard minus the prior year standard, multiplied by the prior year adjusted premium.
The scaling adjustment for two years prior is the current year standard minus the standard from
two years prior, multiplied by the adjusted premium from two years prior. For example, an
issuer subject to a 67% MLR standard in 2011, a 75% standard in 2012, and an 80% MLR
standard in 2013, with adjusted premiums of $1,000,000, $1,200,000, and $1,300,000 in 2011,
2012, and 2013, respectively, would have an adjustment of (80% - 75%) * $1,200,000 and
(80% - 67%) * $1,000,000 = $60,000 + $130,000 = $190,000 in 2013. Note that the scaling
adjustment amount(s) should be added to the Total Column for Line 1.9, and not in the CY,
PY1, or PY2 columns.
Issuers with health insurance coverage in both the individual and small group markets, who
merge their markets in accordance with state law (such as in Massachusetts and the District of
Columbia), should combine Lines 1.2 + 1.3 – 1.4 – 1.5 – 1.6 + 1.8 for both markets and enter
the combined amounts on Line 1.9 in the PY2, PY1, CY, and Total Columns for both markets
(Columns 1-8). Please note that MLR numerator, denominator, and life-years to determine
credibility are the only fields on the MLR Form where experience for the two markets can be
combined.
Section 2 - Medical Loss Ratio Denominator
39

Line 2.1 – Premium earned including Federal and State high risk programs
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 3, Line 2.1, Column CY
CY Column – (Part 1, Lines 1.1 + 1.2 + 1.3, Columns 3/31 + Deferred PY1 – Deferred CY) –
(Part 3, Lines 1.5 + 1.6, Column CY)
Line 2.2 – Federal and State taxes and licensing or regulatory fees
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 3, Line 2.2, Column CY
CY Column –
Federal tax-exempt issuers:
Part 1, Lines 3.1a + 3.1b + 3.1d + 3.2a + 3.2b + 3.2c + 3.3a + 3.3b, Columns 3/31 +
Deferred PY1 – Deferred CY
Non Federal tax-exempt issuers:
Part 1, Lines 3.1a + 3.1b + 3.1d + 3.2a + (the higher of 3.2b or 3.2c) + 3.3a + 3.3b,
Columns 3/31 + Deferred PY1 – Deferred CY
Note: If Line 3.2b is negative and Line 3.2c is zero or blank (or vice versa), zero
may not be used as the higher of the two: only the negative amount may be
used in the equation.
Line 2.3 – MLR denominator
All Columns – Lines 2.1 – 2.2
For Health Insurance Coverage and Mini-med plans respectively, issuers with experience in both
the individual and small group markets who merge markets in accordance with state law (such as
in Massachusetts and the District of Columbia), should combine Lines 2.1 – 2.2 for both markets
and enter the combined amounts on Line 2.3 in the PY2, PY1, CY, and Total Columns for both
markets (Columns 1-8). Please note that MLR numerator, denominator, and life-years to
determine credibility, are the only fields on the MLR Form where experience for the two markets
may be combined.
Section 3 – Credibility Adjustment
Line 3.1 – Life-years
PY2 and PY1 Columns – 2020 and 2021 MLR Forms, respectively, Part 1, Line 7.5, Columns
3/31 + Deferred PY1 – Deferred CY
CY Column – Part 1, Line 7.5, Columns 3/31 + Deferred PY1 – Deferred CY
For Health Insurance Coverage and Mini-med plans respectively, issuers with experience in both
the individual and small group markets who merge their markets in accordance with state law
(such as in Massachusetts and the District of Columbia), should combine Line 3.1 for both
40

markets and enter the combined amounts on Line 3.1 in the PY2, PY1, CY, and Total Columns for
both markets (Columns 1-8). Please note that MLR numerator, denominator, and life-years to
determine credibility are the only fields on the MLR Form where experience for the two markets
may be combined.
Line 3.2 – Base credibility factor
Non-credible experience: An issuer with aggregated life-years of less than 1,000 as reported in
Line 3.1, Total Column for the relevant market is presumed to meet or exceed the applicable MLR
standard and does not receive a credibility adjustment.
Fully credible experience: An issuer with 75,000 or more aggregated life-years as reported in Line
3.1, Total Column for the relevant market does not receive a credibility adjustment. Enter zero
(0%) or leave blank.
Partially credible experience: An issuer with at least 1,000 but fewer than 75,000 aggregated lifeyears as reported in Line 3.1, Total Column for the relevant market may receive a base credibility
factor calculated as follows:
Beginning with the 2013 reporting year, the credibility adjustment for an MLR based on partially
credible experience is zero if both of the following conditions are met:
(1) The current MLR reporting year and each of the two previous MLR reporting years
included experience of at least 1,000 life-years; and
(2) Without applying any credibility adjustment, the issuer’s preliminary MLR for the current
MLR reporting year and each of the two previous MLR reporting years were below the
applicable MLR standard for each year.
Specifically, the base credibility factor is zero if all of the following conditions are met:
• Line 3.1, PY2 Column is at least 1,000; and
• Line 3.1, PY1 Column is at least 1,000; and
• Line 3.1, CY Column is at least 1,000; and
• Line 4.1, PY2 Column is less than Line 5.1, PY2 Column; and
• Line 4.1, PY1 Column is less than Line 5.1, PY1 Column; and
• Line 4.1, CY Column is less than Line 5.1, CY Column.
Otherwise, if the aggregated life-years as reported in Line 3.1, Total Column exactly matches a
life-year category listed in Table 1 below, the value associated with that number of life-years is the
base credibility factor. The base credibility factor for a number of life-years between the values
shown in Table 1 is determined by linear interpolation. DO NOT ROUND.

41

Table 1
Life Years
< 1,000
1,000
2,500
5,000
10,000
25,000
50,000
>= 75,000

Base credibility factor
No Credibility
8.3%
5.2%
3.7%
2.6%
1.6%
1.2%
0.0% (Full Credibility)

Line 3.3 – Average deductible
Issuers who choose to use a deductible factor of 1.0 can skip Steps 1 and 2, leave Line 3.3 blank,
and enter 1.0 on Line 3.4.
Step 1: Calculate average deductibles separately for policies in force in PY2, PY1, and CY.
The per-person deductible for a policy that covers a subscriber and the subscriber’s
dependents shall be calculated as follows:
The lesser of the deductible applicable to each of the individual family members or
the overall family deductible for the subscriber and subscriber’s family divided by
two (regardless of the total number of individuals covered through the subscriber).
Issuers offering products with differing deductibles should use a weighted average based
upon life-years for each deductible level of policies included in the aggregation.
Step 2: Calculate the weighted average (based upon life-years) of the PY2, PY1, and CY average
deductibles computed in Step 1. Enter this three-year weighted average deductible on Line 3.3.
For Health Insurance Coverage and Mini-med plans respectively, issuers with experience in both
the individual and small group markets who merge their markets in accordance with state law
(such as in Massachusetts and the District of Columbia), should calculate the averages across
both markets such that the average deductible is the same for both markets (Columns 4 and 8).
Line 3.4 – Deductible factor
This amount is calculated based upon the average deductible reported in the Total Column for
Line 3.3. The deductible factor ranges from 1.0 to 1.736 and is shown in Table 2 below and in the
Tables tab of the MLR Form. When the average deductible used to determine the deductible factor
exactly matches a deductible level listed in Table 2, the deductible factor associated with that
average deductible level is the factor in Table 2. The deductible factor for a deductible level
between the values shown in Table 2 is determined by linear interpolation (do not round).
Table 2

42

Health plan deductible
< $2,500
$2,500
$5,000
>= $10,000

Deductible Factor
1.000
1.164
1.402
1.736

Enter the amount from the table corresponding with the average deductible. Issuers with noncredible or fully credible experience do not have a deductible factor and can enter a value of 1.0.
Line 3.5 – Credibility adjustment
Lines 3.2 x 3.4 (DO NOT ROUND)
Issuers with non-credible or fully credible experience do not receive a credibility adjustment and
should enter zero.
Section 4 – Medical Loss Ratio Calculation
Issuers with less than 1,000 aggregated life-years (Line 3.1, Total Column) are presumed to meet the
MLR standard and may leave Section 4 blank.
Line 4.1 – Preliminary Medical Loss Ratio
All Columns – Line 1.9 / Line 2.3. Do not round.
Line 4.2 – Credibility adjustment
Line 3.5, Total Column.
Line 4.3 – MLR including credibility adjustment (if applicable)
Lines 4.1+ 4.2, Total Column. After adding, round to three decimal places, e.g. 0.801 or 80.1%.
Section 5 – MLR Rebate Calculation
Line 5.1 – MLR Standard
PY2 Column – 2020 MLR Form, Part 3, Line 5.1, Total Column
PY1 Column – 2021 MLR Form, Part 3, Line 5.1, Total Column
CY and Total Columns – The applicable MLR standard is based on one of the following:
• The statutory MLR standard for the relevant market (i.e., 80% for the individual market
and small group market; and 85% for the large group market); or
• The HHS-approved adjusted MLR standard for a particular State’s individual market; or
• The State MLR standard, if the State requires a higher percentage than the statutory MLR
standard for the relevant market for rebate purposes. In 2022, the following States had
higher MLR standards: MA – 88% (individual and small group markets); NY – 82%
(individual and small group markets).
43

•

If an issuer thinks a State’s higher MLR standard does not apply to its MLR and rebate
requirements under Federal law, please contact CCIIO at MLRQuestions@cms.hhs.gov.

Line 5.2 – Credibility-adjusted MLR
Line 4.3, Total Column
Line 5.3 – Adjusted earned premium
Lines 2.1 – 2.2, CY Column only
Line 5.4 – Rebate amount if credibility-adjusted MLR is less than the MLR standard
(Lines 5.1 – 5.2) x Line 5.3, Total Column
If Line 5.3 is negative, enter zero ($0) in Line 5.4.
Completing Lines 5.5-5.8 below is OPTIONAL for issuers. Completing these lines generally benefits
new or rapidly growing issuers whose MLRs initially fall below the standard and increase over time.
Electing to not complete Lines 5.5-5.8 on the current reporting year’s MLR Form will not preclude an
issuer from taking advantage of the rebate limiting provision in a future year; the issuer would pro-rate
previously paid rebates in accordance with the alternative instructions for Line 5.6.
Line 5.5 – Single-year rebate liability
PY2 Column – Line 2.3, Column PY2 x (Line 5.1, Column PY2 – (Line 4.1, Column PY2 + Line
4.2, Column Total, rounded to three decimal places)). If the result is less than zero, enter zero.
PY1 Column – Line 2.3, Column PY1 x (Line 5.1, Column PY1 – (Line 4.1, Column PY1 + Line
4.2, Column Total, rounded to three decimal places)). If the result is less than zero, enter zero.
CY Column – Line 2.3, Column CY x (Line 5.1, Column CY – (Line 4.1, Column CY + Line 4.2,
Column Total, rounded to three decimal places)). If the result is less than zero, enter zero.
Line 5.6 – Paid rebate liability
If Lines 5.6 and 5.8 were completed on the MLR Form for the preceding year:
PY2 Column – MLR Form for the preceding year, Part 3, Lines 5.6 + 5.8, Column PY1
PY1 Column – MLR Form for the preceding year, Part 3, Line 5.8, Column CY
Issuers with experience in both the individual and small group markets who merge markets
in accordance with state law (such as in Massachusetts and the District of Columbia),
should combine Line 5.8 amounts from the preceding year’s MLR Form for both markets
and include the combined amount on Line 5.6 in the PY2 and PY1 Columns for both
markets on the current year’s MLR Form. Line 5.6 on the preceding year’s MLR Form
should already reflect a combined amount.
44

An issuer who paid a higher state than federal MLR rebate under a state MLR calculation
that utilizes a single year of data rather than a multi-year average MLR or under a state
calculation that utilizes multi-year data in both the MLR and rebate calculations (such as
New Jersey and New Mexico) may substitute such higher state MLR rebate on Line 5.6.
If an issuer prepaid MLR rebates in advance of filing the MLR Form for a prior year, the
issuer may include such prepaid amount on Line 5.6 even if it exceeds the rebate amount
calculated on Line 5.4 of the MLR Form for the relevant prior year (to the extent not
recouped from the enrollees).
Alternative instructions:
If Line 5.8 was not completed on the MLR Form for the preceding year, pro-rate non-zero prior
year rebate amounts as shown below. For users’ convenience, CMS will provide on its website 4
an Excel spreadsheet automating this calculation. In lieu of pro-rating using the formulas below,
an issuer may choose to calculate the paid rebate liability for each of the previous years’ MLR
Forms using the formulas for Lines 5.5-5.8. All references to Line 3.5 below mean Line 3.5 in
Column Total.
Step 1: Using the 2021 MLR Form, Part 3:
•

2020 paid rebate liability: Line 5.4, Column Total x [Lines 2.3 x (5.1 – 4.1 – 3.5),
Column PY1] / [Lines 2.3 x (5.1 – 4.1 – 3.5), Column PY2 + Lines 2.3 x (5.1 – 4.1
– 3.5), Column PY1 + Lines 2.3 x (5.1 – 4.1 – 3.5), Column CY].

•

2021 paid rebate liability: Line 5.4, Column Total x [Lines 2.3 x (5.1 – 4.1 – 3.5),
Column CY] / [Lines 2.3 x (5.1 – 4.1 – 3.5), Column PY2 + Lines 2.3 x (5.1 – 4.1 –
3.5), Column PY1 + Lines 2.3 x (5.1 – 4.1 – 3.5), Column CY]

•

Note: If Line 2.3 is negative or blank for any column above, use $0 as the value for
Line 2.3 in that column. If the result of Lines (5.1 – 4.1 – 3.5) is negative for any
column, use 0% as the value for Lines (5.1 – 4.1 – 3.5) in that column. If Line 4.1
was blank for any column because the business in that column was non-credible,
calculate the value for Line 4.1 by dividing Line 1.9 by Line 2.3.

For example, if on the 2021 MLR Form, Part 3, Individual market:
a) Line 2.3 shows $30,000 in Column PY2, $90,000 in Column PY1, and $100,000 in
Column CY;
b) Line 3.5 shows 0% in Column Total;
c) Line 4.1 shows 60% in Column PY2, 70% in Column PY1, and 83% in Column CY;
d) Line 5.1 shows an 80% MLR standard in all columns;
e) Line 5.4 shows $5,500 in Column Total;
then the $5,500 rebate payment would be pro-rated as follows:
o 2020 paid rebate liability = $5,500 x $90,000 x (80% – 70% – 0%) / [$30,000 x
(80% – 60% – 0%) + $90,000 x (80% – 70% – 0%) + $100,000 x 0% (0% is used
because 80% – 83% is less than zero)] = $3,300;

4

https://www.cms.gov/cciio/Resources/Forms-Reports-and-Other-Resources/index.html#Medical_Loss_Ratio

45

o 2021 paid rebate liability = $5,500 x $100,000 x 0% (0% is used because 80% –
83% is less than zero) / [$30,000 x (80% – 60% – 0%) + $90,000 x (80% – 70% –
0%) + $100,000 x 0% (0% is used because 80% – 83% is less than zero)] = $0.
In this example, $3,300 would be included on the 2022 MLR Form, Part 3, Line 5.6,
Column PY2; and $0 would be included on the 2022 MLR Form, Part 3, Line 5.6, Column
PY1.
Step 2: Using the 2020 MLR Form, Part 3:
•

2020 paid rebate liability: Line 5.4, Column Total x [Lines 2.3 x (5.1 – 4.1 – 3.5),
Column CY] / [Lines 2.3 x (5.1 – 4.1 – 3.5), Column PY2 + Lines 2.3 x (5.1 – 4.1 –
3.5), Column PY1 + Lines 2.3 x (5.1 – 4.1 – 3.5), Column CY]

•

Note: If Line 2.3 is negative or blank for any column above, use $0 as the value for
Line 2.3 in that column. If the result of Lines (5.1 – 4.1 – 3.5) is negative for any
column, use 0% as the value for Lines (5.1 – 4.1 – 3.5) in that column. If Line 4.1
was blank for any column because the business in that column was non-credible,
calculate the value for Line 4.1 by dividing Line 1.9 by Line 2.3.

For example, if on the 2020 MLR Form, Part 3, Individual market:
a) Line 2.3 shows $5,000 in Column PY2, $30,000 in Column PY1, and $90,000 in
Column CY;
b) Line 3.5 shows 1.0% in Column Total;
c) Line 4.1 shows blank in Column PY2, 60% in Column PY1, and 70% in Column CY;
d) Line 1.9 shows $2,000 in Column PY2;
e) Line 5.1 shows an 80% MLR standard in all columns;
f) Line 5.4 shows $11,340 in Column Total;
then the $11,340 rebate payment would be pro-rated as follows:
o 2020 paid rebate liability = $11,340 x $90,000 x (80% – 70% – 1%) / [$5,000 x
(80% – $2,000/$5,000 – 1%) ($2,000/$5,000 is used because Line 4.1 is blank) +
$30,000 x (80% – 60% – 1%) + $90,000 x (80% – 70% – 1%)] = $5,832.
Include the result on the 2022 MLR Form, Part 3, Line 5.6, Column PY2 together with the
2020 amount obtained in Step 1.
Issuers with experience in both the individual and small group markets who merge markets in
accordance with state law (such as in Massachusetts and the District of Columbia), should
combine the resulting prior year amounts for both markets and enter the combined amounts on
Line 5.6 in the PY2 and PY1 Columns for both markets.
Line 5.7 – Unpaid rebate liability
Lines 5.5 – 5.6 (if less than zero, enter zero)
Line 5.8 – Limited payable rebate amount
PY2 Column – The lesser of Line 5.7, Column PY2 and Line 5.4, Column Total

46

PY1 Column – The lesser of Line 5.7, Column PY1 and (Line 5.4, Column Total – Line 5.8,
Column PY2)
CY Column – The lesser of Line 5.7, Column CY and (Line 5.4, Column Total – Line 5.8,
Column PY1 – Line 5.8, Column PY2)
Issuers with experience in both the individual and small group markets who merge markets in
accordance with state law (such as in Massachusetts and the District of Columbia), should adjust
the formulas above by multiplying Line 5.7 by the ratio of Lines (2.1 – 2.2) / 2.3 in the respective
columns.
Section 6 – Temporary Adjustments
Reserved

47

Instructions for MLR Annual Reporting Form – Part 4
(Rebate Disbursement)
These MLR Form Filing Instructions apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions may be revised to reflect changes that apply to the filing years
subsequent to 2022.
The Column Definitions, which immediately follow the General Instructions at the beginning of these
Filing Instructions, apply to the markets to be reported in Columns 1 through 9 of Part 4.
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
Column 7
Column 8
Column 9

–
–
–
–
–
–
–
–
–

Individual Market
Small Group Market
Large Group Market
Mini-Med plans – Individual Market
Mini-Med plans – Small Group Market
Mini-Med plans – Large Group Market
Expatriate plans – Small Group Market (not applicable in 2022)
Expatriate plans – Large Group Market (not applicable in 2022)
Student Health plans – Individual Market

Additional definitions:
•

Group Policyholder means any entity that has entered into a contract with an issuer to receive health
insurance coverage. (Applicable only in the group markets.)

•

Subscriber (Applicable in all markets.)
o In the individual market, subscriber means the person who purchases an individual policy and
who is responsible for the payment of premiums. This does not include the number of
dependents and therefore does not correspond to the number of covered lives or life-years;
rather, this corresponds to the number of individual policies.
o In the group market, subscriber means the person, generally the employee, whose eligibility is
the basis for the enrollment in the group health plan and who is responsible for the payment of
premiums. This does not correspond to the number of group policyholders (e.g. employers).
This also does not include the number of dependents and therefore does not correspond to the
number of covered lives or life-years; rather, this corresponds to the number of certificates
(e.g. number of employees).

Section/Line 1 – Number of policies/certificates (from Part 1, Line 7.1)
Section 2 – Number of policyholders/subscribers owed rebates
Line 2.a – Number of group policyholders who are being paid a rebate (only applicable in the group
markets)
Include:

All group policies (e.g. employers) within the respective group markets that are due a
rebate and to whom the issuer is paying the rebate directly. This is a count of the
groups, not a count of the certificates, covered lives, or life-years in the groups.
48

Exclude: Rebates being paid in the individual market and rebates in group markets which the
issuer is paying directly to the group’s subscribers rather than to the group
policyholder.
Line 2.b – Number of subscribers being paid a rebate
•
•

Individual market: All subscribers under individual policies that are due a rebate. This does
not include dependents; consequently, this is not the number of covered lives or life-years.
Small and large group markets: Those subscribers to whom the issuer is paying the rebate
directly. This does not include subscribers where the issuer is paying the rebate to the group
policyholder. This is not the number of employers, covered lives or life-years; typically, this
is the number of employees (not including dependents).

Line 2.c – Number of group policyholders whose calculated rebate is de minimis
De Minimis –
• For a group policy for which the issuer distributes the rebate directly to the policyholder, if
the total rebate owed to the policyholder and its subscribers combined is less than $20 for
the MLR reporting year. This is not the number of certificates, covered lives or life-years;
typically, this is the number of employers.
Line 2.d – Number of subscribers whose calculated rebate is de minimis
De Minimis –
• For a group policy for which the issuer distributes the rebate directly to the subscribers, if
the total rebate owed to each subscriber is less than $5 for a given MLR reporting year.
This is not the number of employers, covered lives or life-years; typically, this is the
number of employees (not including dependents).
• For an individual policy, if the total rebate owed to each subscriber is less than $5 for a
given MLR reporting year. This does not include dependents; consequently, this is not the
number of covered lives or life-years.
Section 3 – Total amount of rebates
Line 3.a – Total amount of rebates (from Part 3, Line 5.4 or 5.8, as applicable)
Line 3.b – Total amount of de minimis rebates
Line 3.c – Amount of rebates being paid by premium credit
Line 3.d – Amount of rebates being paid by lump-sum reimbursement
Line 3.e – Amount of rebates prepaid in advance of filing the MLR Form
Section 4 – Prior MLR year rebates
Line 4.a – Total amount of rebates paid for the previous MLR reporting year
49

Line 4.b – Total amount of rebates still owed for the previous MLR reporting year
Line 4.c – Percentage of rebate notices timely sent to individual and group policyholders owed a rebate
Enter the percentage of notices sent by September 30 following the prior MLR reporting year.
Line 4.d – Percentage of notices timely sent to subscribers of group policies owed a rebate
Enter the percentage of notices sent by September 30 following the prior MLR reporting year.
Line 4.e – Percentage of rebate amounts timely paid to individual and group policyholders owed a rebate
Include:
• Rebate amounts paid as a lump-sum check or reimbursement to individual policyholders
and directly to group policyholders (e.g., on the form filed for the 2022 MLR reporting
year, this line would include rebates for the 2021 MLR reporting year that were disbursed
as a lump sum by September 30, 2022)
• Rebate amounts that begun to be credited to individual policyholders and directly to group
policyholders for the premium due no later than October 30 following the prior MLR
reporting year (e.g., on the form filed for the 2022 MLR reporting year, this line would
include the percentage of rebates based upon the 2021 MLR reporting year that were paid
as premium credit beginning on or before October 30, 2022)
Exclude: Rebates in group markets which the issuer paid directly to the group’s subscribers rather
than to the group policyholder.
Line 4.f – Percentage of rebates amounts timely paid directly to subscribers of group policies owed a
rebate
Enter the percentage of rebate amounts paid by September 30 following the prior MLR reporting
year, for rebates which the issuer paid directly to the group’s subscribers rather than to the group
policyholder.
Line 4.g – Amount of unclaimed rebates from all prior MLR reporting years
Report rebate checks issued but not presented for payment. Report the amount of rebates owed
based on the previous MLR reporting years which remain unpaid because the issuer was unable,
after making a good faith effort, to locate a former policyholder or subscriber, and which have not
yet been escheated or otherwise disbursed.
Line 4.h – Describe the methods used to locate policyholders/subscribers to distribute the prior MLR
reporting years’ unclaimed rebates
Line 4.i – Disbursement method of the prior MLR reporting years’ unclaimed rebates
Describe the method used to disburse the prior MLR reporting years’ unclaimed rebates.

50

Instructions for MLR Annual Reporting Form – Part 5
(Additional Responses)
These MLR Form Filing Instructions apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions may be revised to reflect changes that apply to the filing years
subsequent to 2022.
Line 1 – If the issuer reported amounts in Part 1, Line 3.2c, Community Benefit Expenditures, provide the
state premium tax rate that was used in determining the reported amount (provide the actual tax
rate rather than the flat 3% floor that may apply for some issuers exempt from Federal income
tax). Complete on each State template and not on the GT template.
Line 2 – If the issuer reported amounts in Part 2, Line 2.15, Blended rate adjustment, provide the
affiliate(s)’ name(s) for which blended rate adjustments were made.
Line 3 – If the issuer reported amounts in the 3/31 Columns related to dual contract options with affiliates
providing out-of-network coverage, provide the affiliate(s)’ name(s) for which experience is
being reported.
Line 4 – If the issuer entered into any 100% assumption reinsurance agreements (with a novation) during
the MLR reporting year provide the name(s) of the entity(ies) with which the agreement was
(were) made and the effective date of the novation. Report only those agreements that are
applicable to “health insurance coverage” as defined at the beginning of these Filing
Instructions.
Line 5 – If the issuer sold any business in the MLR reporting year, and the novation was effective during
the MLR reporting year, provide the name(s) of the entity(ies) to which the business was sold
and the date of the sale or transfer.
Line 6 – If the issuer has any 100% indemnity reinsurance and administrative agreements effective prior
to March 23, 2010, for which the assuming entity is responsible for 100 percent of the ceding
entity’s financial risk and takes on all of the administration of the block of business, provide
name(s) of the entity(ies) that is (are) reporting the experience related to such business. Report
only those agreements that are applicable to “health insurance coverage” as defined at the
beginning of these Filing Instructions.

51

Instructions for MLR Annual Reporting Form − Part 6
(Expense Allocation Methodology)
These MLR Form Filing Instructions apply to the 2022 MLR reporting year and its reporting
requirements. These Filing Instructions may be revised to reflect changes that apply to the filing years
subsequent to 2022. Complete Part 6 only within the GT template.
Description of Methods to Allocate Expenses
Describe the methods used to allocate expenses, as reported on the MLR Form, including incurred claims,
quality improvement expenses, Federal and State taxes and licensing or regulatory fees, and other nonclaims costs, to each health insurance market (e.g., individual, small group, large group, mini-med plans,
expatriate plans, government program plans, other health business, and uninsured plans, each as defined
in the Column Definitions at the beginning of these Filing Instructions) in each State.
A detailed description of each expense element must be provided, including how each specific expense
meets the criteria for the type of expense in which it is categorized, as well as the method by which it was
aggregated. (See instructions within Parts 1 and 2 for descriptions of the various expense elements.)
For a new initiative that otherwise meets the definition of quality improvement activities (QI) (see Filing
Instructions for Part 1) but has not yet met the requirement that it be capable of being objectively
measured and of producing verifiable results and achievements, note that it is “NEW” in the description
of the QI and include the expected timeframe for the activity to meet this requirement.
Acceptable Bases for Allocation of Expenses
Allocation of each type of expense among health insurance markets should be based on a generally
accepted accounting method that is expected to yield the most accurate results. If this is not feasible, the
issuer should provide an explanation as to why it believes a more accurate result will be gained from its
allocation of expenses, including pertinent factors or ratios, such as studies of employee activities, salary
ratios or similar analyses.
Many entities operate within a group where personnel and facilities are shared. Shared expenses,
including expenses under the terms of a management or administrative services contract, must be
apportioned pro rata to the entities incurring the expense.
Any basis adopted to apportion expenses must be that which is expected to yield the most accurate results
and may result from special studies of employee activities, salary ratios, premium ratios or similar
analyses. Expenses that relate to a specific entity or sub-set of entities, such as personnel costs associated
with the adjusting and paying of claims, must be borne solely by that specific entity or subset of entities
and must not be apportioned to other entities within a group.
Line References
Line 1 – Incurred Claims (as reported on Part 2, Lines 2.1 through 2.16)
Line 2 – Federal and State Taxes and Licensing or Regulatory Fees (as reported on Part 1, Section 3)
Line 2.a – Federal taxes and assessments (as reported on Part 1, Lines 3.1a-d)
52

Line 2.b – State insurance, premium, and other taxes (as reported on Part 1, Lines 3.2a and 3.2b)
Line 2.c – Community benefit expenditures (as reported on Part 1, Line 3.2c)
Line 2.d – Regulatory authority licenses and fees (as reported on Part 1, Lines 3.3a and 3.3b)
Line 3 – Quality Improvement Expenses (as reported on Part 1, Section 4)
Line 3.a – Improve health outcomes (as reported on Part 1, Line 4.1)
Line 3.b – Activities to prevent hospital readmission (as reported on Part 1, Line 4.2)
Line 3.c – Improve patient safety and reduce medical errors (as reported on Part 1, Line 4.3)
Line 3.d – Wellness and health promotion activities (as reported on Part 1, Line 4.4)
Line 3.e – Health Information Technology (HIT) expenses related to health improvement (as
reported on Part 1, Line 4.5)
Line 4 – Non-claims Costs (as reported on Part 1, Section 5)
Line 4.a – Cost containment expenses (as reported on Part 1, Line 5.1)
Line 4.b – All other claims adjustment expenses (as reported on Part 1, Line 5.2)
Line 4.c – Direct sales salaries and benefits (as reported on Part 1, Line 5.3)
Line 4.d – Agents and brokers fees and commissions (as reported on Part 1, Line 5.4)
Line 4.e – Other taxes (as reported on Part 1, Line 5.5a-c)
Line 4.f – Other general and administrative expenses (as reported on Part 1, Line 5.6)
Line 4.g – Community benefit expenditures (as reported on Part 1, Line 5.7)

53